<?xml version="1.0" encoding="UTF-8" standalone="yes"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><generator>NFE/5.0</generator><title>"환인제약" - Google 뉴스</title><link>https://news.google.com/search?cf=all&amp;hl=ko&amp;q=%ED%99%98%EC%9D%B8%EC%A0%9C%EC%95%BD&amp;cf=all&amp;gl=KR&amp;ceid=KR:ko</link><language>ko</language><webMaster>news-webmaster@google.com</webMaster><copyright>Copyright © 2026 Google. All rights reserved. This XML feed is made available solely for the purpose of rendering Google News results within a personal feed reader for personal, non-commercial use. Any other use of the feed is expressly prohibited. By accessing this feed or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><lastBuildDate>Sat, 16 May 2026 21:55:17 GMT</lastBuildDate><image><title>Google 뉴스</title><url>https://lh3.googleusercontent.com/-DR60l-K8vnyi99NZovm9HlXyZwQ85GMDxiwJWzoasZYCUrPuUM_P_4Rb7ei03j-0nRs0c4F=w256</url><link>https://news.google.com/</link><height>256</height><width>256</width></image><description>Google 뉴스</description><item><title>환인제약, 제품 중심 전략 통했다…1분기 ‘어닝 서프라이즈’ - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5oOUdIUmJFSXBUWWVyUHFlRXZzcUJKV3cxOTN0Ty1HaW9wd2NGaUFTa3hZdHlzZlpHUVJIX3ZuQ0l3akJZUm5ZLU5KaDJXYWlrUjN0Q3FkREt4dW1LWnh1R2NDd2JQc05nV1dCSg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5oOUdIUmJFSXBUWWVyUHFlRXZzcUJKV3cxOTN0Ty1HaW9wd2NGaUFTa3hZdHlzZlpHUVJIX3ZuQ0l3akJZUm5ZLU5KaDJXYWlrUjN0Q3FkREt4dW1LWnh1R2NDd2JQc05nV1dCSg</guid><pubDate>Wed, 13 May 2026 20:50:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5oOUdIUmJFSXBUWWVyUHFlRXZzcUJKV3cxOTN0Ty1HaW9wd2NGaUFTa3hZdHlzZlpHUVJIX3ZuQ0l3akJZUm5ZLU5KaDJXYWlrUjN0Q3FkREt4dW1LWnh1R2NDd2JQc05nV1dCSg?oc=5" target="_blank"&gt;환인제약, 제품 중심 전략 통했다…1분기 ‘어닝 서프라이즈’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>환인제약, 1분기 역대 최대 매출 달성…수익성 예년 수준 회복 - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBrZU1hQXlucjZ5ZHBkZzdGcWZPWk9LaG40UmhLQXQ3eHUwMXhUQ3lIT01FQjB0ZzVJaUR0QmQ5X1g5d2dzakJQUlB5U2VoTS1FNzdSZmdFNFJweGpqVGQyWjJ0QnFrdEkwZEpR?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBrZU1hQXlucjZ5ZHBkZzdGcWZPWk9LaG40UmhLQXQ3eHUwMXhUQ3lIT01FQjB0ZzVJaUR0QmQ5X1g5d2dzakJQUlB5U2VoTS1FNzdSZmdFNFJweGpqVGQyWjJ0QnFrdEkwZEpR</guid><pubDate>Fri, 15 May 2026 02:44:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBrZU1hQXlucjZ5ZHBkZzdGcWZPWk9LaG40UmhLQXQ3eHUwMXhUQ3lIT01FQjB0ZzVJaUR0QmQ5X1g5d2dzakJQUlB5U2VoTS1FNzdSZmdFNFJweGpqVGQyWjJ0QnFrdEkwZEpR?oc=5" target="_blank"&gt;환인제약, 1분기 역대 최대 매출 달성…수익성 예년 수준 회복&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>환인제약, 파킨슨·조현병 신약 중단…품목 재편 - 데일리메디</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTFBnaGZ5QjJJRjAwWVZqazFTcHVsV3kxN011dVJxRmZsdXVtQlZNYjJwZ00zX3lib0x0RGxzYXdXbi1xX1ZYanRXSXU1NkxlTEdlVGZCalR5VXhpdmtWVUI1eENsRkhuVHJB?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTFBnaGZ5QjJJRjAwWVZqazFTcHVsV3kxN011dVJxRmZsdXVtQlZNYjJwZ00zX3lib0x0RGxzYXdXbi1xX1ZYanRXSXU1NkxlTEdlVGZCalR5VXhpdmtWVUI1eENsRkhuVHJB</guid><pubDate>Fri, 17 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTFBnaGZ5QjJJRjAwWVZqazFTcHVsV3kxN011dVJxRmZsdXVtQlZNYjJwZ00zX3lib0x0RGxzYXdXbi1xX1ZYanRXSXU1NkxlTEdlVGZCalR5VXhpdmtWVUI1eENsRkhuVHJB?oc=5" target="_blank"&gt;환인제약, 파킨슨·조현병 신약 중단…품목 재편&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리메디&lt;/font&gt;</description><source url="https://www.dailymedi.com">데일리메디</source></item><item><title>환인제약, 가이던스 달성 여부 '해외·신사업'이 가른다 - fetv.co.kr</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTFBLNWgtdngtVC1WOXhYeG00WEIxbEhMNl9WamVpSEtMZUdtTWZBVHA2V2FzdHNLTzg2N0hERFp3dnpxRVEtNUw0Um1fWXRQLXRPNmZpRHV0dUpqUmtibm5QRUhOR3pyNTdX?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTFBLNWgtdngtVC1WOXhYeG00WEIxbEhMNl9WamVpSEtMZUdtTWZBVHA2V2FzdHNLTzg2N0hERFp3dnpxRVEtNUw0Um1fWXRQLXRPNmZpRHV0dUpqUmtibm5QRUhOR3pyNTdX</guid><pubDate>Wed, 29 Apr 2026 05:04:36 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTFBLNWgtdngtVC1WOXhYeG00WEIxbEhMNl9WamVpSEtMZUdtTWZBVHA2V2FzdHNLTzg2N0hERFp3dnpxRVEtNUw0Um1fWXRQLXRPNmZpRHV0dUpqUmtibm5QRUhOR3pyNTdX?oc=5" target="_blank"&gt;환인제약, 가이던스 달성 여부 '해외·신사업'이 가른다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;fetv.co.kr&lt;/font&gt;</description><source url="https://www.fetv.co.kr">fetv.co.kr</source></item><item><title>'한 우물' 환인제약, 2세경영 본격화…기업가치 제고 속도낼까 - 톱데일리</title><link>https://news.google.com/rss/articles/CBMiUEFVX3lxTFBrMldBOXN3MTdVaDlXbTQxRnVBLXYwZkJYanpVbE1TeGZRTVV4bDdxdV8tTmJBaFpmX2tMUndsYm1fN1FxWWpXdlB3MGk5eEVM?oc=5</link><guid isPermaLink="false">CBMiUEFVX3lxTFBrMldBOXN3MTdVaDlXbTQxRnVBLXYwZkJYanpVbE1TeGZRTVV4bDdxdV8tTmJBaFpmX2tMUndsYm1fN1FxWWpXdlB3MGk5eEVM</guid><pubDate>Fri, 08 May 2026 07:12:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFBrMldBOXN3MTdVaDlXbTQxRnVBLXYwZkJYanpVbE1TeGZRTVV4bDdxdV8tTmJBaFpmX2tMUndsYm1fN1FxWWpXdlB3MGk5eEVM?oc=5" target="_blank"&gt;'한 우물' 환인제약, 2세경영 본격화…기업가치 제고 속도낼까&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;톱데일리&lt;/font&gt;</description><source url="https://www.topdaily.kr">톱데일리</source></item><item><title>[경력채용] 환인제약, 보령, 유유제약, 휴온스메디텍, 보로노이 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE40ZTB2ZVdCNFFHQU1WY0RlTE5NUk1LaTVNYVNjeEVpb0xWd1hvcDBRVHhNSkhPamYxZmpuNERwU2NyRzJxRXZrNWtmNjZUVFptV2o2SFdXaHNCa3Vlci02QU01QU53VlcyU1Fn?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE40ZTB2ZVdCNFFHQU1WY0RlTE5NUk1LaTVNYVNjeEVpb0xWd1hvcDBRVHhNSkhPamYxZmpuNERwU2NyRzJxRXZrNWtmNjZUVFptV2o2SFdXaHNCa3Vlci02QU01QU53VlcyU1Fn</guid><pubDate>Wed, 22 Apr 2026 21:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE40ZTB2ZVdCNFFHQU1WY0RlTE5NUk1LaTVNYVNjeEVpb0xWd1hvcDBRVHhNSkhPamYxZmpuNERwU2NyRzJxRXZrNWtmNjZUVFptV2o2SFdXaHNCa3Vlci02QU01QU53VlcyU1Fn?oc=5" target="_blank"&gt;[경력채용] 환인제약, 보령, 유유제약, 휴온스메디텍, 보로노이&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>국내 CNS 1위는 어디? 명인제약 vs 환인제약[용호상박 K바이오] - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE9LZGdZUU4wdUdsbnJfclM0UnZSRmJSN0VReUNRd1NPSEtna0dJQW1pNnE3M2V2WHVteWFEX1h5T3Q4VUVtU1RWcXhKalhVOC01ZXhEYTJLS2Rja0hTaEFqMlFTR0kzaVdRdFZFcTJR?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE9LZGdZUU4wdUdsbnJfclM0UnZSRmJSN0VReUNRd1NPSEtna0dJQW1pNnE3M2V2WHVteWFEX1h5T3Q4VUVtU1RWcXhKalhVOC01ZXhEYTJLS2Rja0hTaEFqMlFTR0kzaVdRdFZFcTJR</guid><pubDate>Tue, 02 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9LZGdZUU4wdUdsbnJfclM0UnZSRmJSN0VReUNRd1NPSEtna0dJQW1pNnE3M2V2WHVteWFEX1h5T3Q4VUVtU1RWcXhKalhVOC01ZXhEYTJLS2Rja0hTaEFqMlFTR0kzaVdRdFZFcTJR?oc=5" target="_blank"&gt;국내 CNS 1위는 어디? 명인제약 vs 환인제약[용호상박 K바이오]&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>[인사] 환인제약, 2026년도 정기 승진 - 의사신문</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTFBfTG1DY1gyNld6c2JkSUlPSFctOERQRTVCcnVXdUxDSkpWMHc0eWhkUnBZa1JnMncyOVVXZHozQWRmcU82VGNTSE1kcG1YdkJGWk90QnVRbFlENF9pY0JCUU1QNjBPLTc2SVVKWjFkcw?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTFBfTG1DY1gyNld6c2JkSUlPSFctOERQRTVCcnVXdUxDSkpWMHc0eWhkUnBZa1JnMncyOVVXZHozQWRmcU82VGNTSE1kcG1YdkJGWk90QnVRbFlENF9pY0JCUU1QNjBPLTc2SVVKWjFkcw</guid><pubDate>Wed, 01 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTFBfTG1DY1gyNld6c2JkSUlPSFctOERQRTVCcnVXdUxDSkpWMHc0eWhkUnBZa1JnMncyOVVXZHozQWRmcU82VGNTSE1kcG1YdkJGWk90QnVRbFlENF9pY0JCUU1QNjBPLTc2SVVKWjFkcw?oc=5" target="_blank"&gt;[인사] 환인제약, 2026년도 정기 승진&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의사신문&lt;/font&gt;</description><source url="http://www.doctorstimes.com">의사신문</source></item><item><title>최대주주 ‘이원범’ 환인제약 대표, ‘수익성’ 부진 어떻게 해결할까 - 시사저널e</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTFBCX1c2S2g4N0EyU0JoNEthTG1EcnoyVE9GNTRnSWNGZks5UnByTXlJR3hQZlZXMVE3S3VCNTM4VF9jYXB2ajNyX1NiQ2VZZ3ltV3NDRmtaUERtYVdoaEhLUXZiay15M3Jlakk5Z2pIN2VWd9IBdkFVX3lxTE5aNWRyOTdfNGs5UHdlX3FFeGtxeFE5SldfUlNwaFFzaUZOMHVjV0RaSndCaEVMMHlWb0hiWXpWemJMQkdLTlRwS2gzRlIwR29zT0l6eXhmX1NyNlB5ZmN6ZUJjQWFVRzdqbnMyT25PRlgyNEtNdEE?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTFBCX1c2S2g4N0EyU0JoNEthTG1EcnoyVE9GNTRnSWNGZks5UnByTXlJR3hQZlZXMVE3S3VCNTM4VF9jYXB2ajNyX1NiQ2VZZ3ltV3NDRmtaUERtYVdoaEhLUXZiay15M3Jlakk5Z2pIN2VWd9IBdkFVX3lxTE5aNWRyOTdfNGs5UHdlX3FFeGtxeFE5SldfUlNwaFFzaUZOMHVjV0RaSndCaEVMMHlWb0hiWXpWemJMQkdLTlRwS2gzRlIwR29zT0l6eXhmX1NyNlB5ZmN6ZUJjQWFVRzdqbnMyT25PRlgyNEtNdEE</guid><pubDate>Mon, 24 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTFBCX1c2S2g4N0EyU0JoNEthTG1EcnoyVE9GNTRnSWNGZks5UnByTXlJR3hQZlZXMVE3S3VCNTM4VF9jYXB2ajNyX1NiQ2VZZ3ltV3NDRmtaUERtYVdoaEhLUXZiay15M3Jlakk5Z2pIN2VWd9IBdkFVX3lxTE5aNWRyOTdfNGs5UHdlX3FFeGtxeFE5SldfUlNwaFFzaUZOMHVjV0RaSndCaEVMMHlWb0hiWXpWemJMQkdLTlRwS2gzRlIwR29zT0l6eXhmX1NyNlB5ZmN6ZUJjQWFVRzdqbnMyT25PRlgyNEtNdEE?oc=5" target="_blank"&gt;최대주주 ‘이원범’ 환인제약 대표, ‘수익성’ 부진 어떻게 해결할까&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;시사저널e&lt;/font&gt;</description><source url="https://www.sisajournal-e.com">시사저널e</source></item><item><title>환인제약, '브리바정' 국내 첫 75mg 포함 전용량 출시 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE1aa3dsTlRpWFJ2TlRSVEM0RHowN3pzSzJRdU5Ga1BmRHE2elpDTjJWYkF2Nk1fR0gwUU1wYlJXcEl5WFN5THJkVGtzMXJwMGJONC1sMGNoYjVHQXJVOGs2T2ZSWWtGUnBTWENjYTZ4eG12OXc?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE1aa3dsTlRpWFJ2TlRSVEM0RHowN3pzSzJRdU5Ga1BmRHE2elpDTjJWYkF2Nk1fR0gwUU1wYlJXcEl5WFN5THJkVGtzMXJwMGJONC1sMGNoYjVHQXJVOGs2T2ZSWWtGUnBTWENjYTZ4eG12OXc</guid><pubDate>Mon, 23 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE1aa3dsTlRpWFJ2TlRSVEM0RHowN3pzSzJRdU5Ga1BmRHE2elpDTjJWYkF2Nk1fR0gwUU1wYlJXcEl5WFN5THJkVGtzMXJwMGJONC1sMGNoYjVHQXJVOGs2T2ZSWWtGUnBTWENjYTZ4eG12OXc?oc=5" target="_blank"&gt;환인제약, '브리바정' 국내 첫 75mg 포함 전용량 출시&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>환인제약, 2026년도 정기 승진인사 단행 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBUTEprUnhSSlFqZ3U5WnczTlpUZC1KaUswTG1WeWFLWV9DRXVYNW9ib2NDVWYxc0R3ME1zUUtxMGpzSk1rNjF1NkdRMkd3OEpNYnZaTFNTdkhBRjZiQjY2bFlFZTFVMVBKaHdldg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBUTEprUnhSSlFqZ3U5WnczTlpUZC1KaUswTG1WeWFLWV9DRXVYNW9ib2NDVWYxc0R3ME1zUUtxMGpzSk1rNjF1NkdRMkd3OEpNYnZaTFNTdkhBRjZiQjY2bFlFZTFVMVBKaHdldg</guid><pubDate>Fri, 03 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBUTEprUnhSSlFqZ3U5WnczTlpUZC1KaUswTG1WeWFLWV9DRXVYNW9ib2NDVWYxc0R3ME1zUUtxMGpzSk1rNjF1NkdRMkd3OEpNYnZaTFNTdkhBRjZiQjY2bFlFZTFVMVBKaHdldg?oc=5" target="_blank"&gt;환인제약, 2026년도 정기 승진인사 단행&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>환인제약, 올해 이익 회복 기대…향남 신공장 부담 완화 주목 - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1lVVRJNjAxUnBqX29iNHc1WS1LN3FMeG0zNFoybmJmbVI4WGxGQnlRZXBiUTZzem5TX3o3UWpzTlpnb3B4ODZMUVRvbEVHNFY5c0xvMm9WSkxIOWJmcXRmd2tEa3Y5TE1GbTcw?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1lVVRJNjAxUnBqX29iNHc1WS1LN3FMeG0zNFoybmJmbVI4WGxGQnlRZXBiUTZzem5TX3o3UWpzTlpnb3B4ODZMUVRvbEVHNFY5c0xvMm9WSkxIOWJmcXRmd2tEa3Y5TE1GbTcw</guid><pubDate>Wed, 25 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1lVVRJNjAxUnBqX29iNHc1WS1LN3FMeG0zNFoybmJmbVI4WGxGQnlRZXBiUTZzem5TX3o3UWpzTlpnb3B4ODZMUVRvbEVHNFY5c0xvMm9WSkxIOWJmcXRmd2tEa3Y5TE1GbTcw?oc=5" target="_blank"&gt;환인제약, 올해 이익 회복 기대…향남 신공장 부담 완화 주목&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>[HIT 포커스] 환인제약은 왜, 자사주를 '흑기사 지분'으로 바꿨나 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE10dG5ad1MyMXZ0eE0wUlotcXg5ZXhyMS1nWFVVdWlGdzJuQ2FURlpjaE9ZTzRwWDhsNEtDZktPNS1KRVk3WmNXdmJpUTJEcW1MTmpFY3ZwSXg1MVZhczh5cFRUM3RaU0c4dVMw?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE10dG5ad1MyMXZ0eE0wUlotcXg5ZXhyMS1nWFVVdWlGdzJuQ2FURlpjaE9ZTzRwWDhsNEtDZktPNS1KRVk3WmNXdmJpUTJEcW1MTmpFY3ZwSXg1MVZhczh5cFRUM3RaU0c4dVMw</guid><pubDate>Fri, 12 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE10dG5ad1MyMXZ0eE0wUlotcXg5ZXhyMS1nWFVVdWlGdzJuQ2FURlpjaE9ZTzRwWDhsNEtDZktPNS1KRVk3WmNXdmJpUTJEcW1MTmpFY3ZwSXg1MVZhczh5cFRUM3RaU0c4dVMw?oc=5" target="_blank"&gt;[HIT 포커스] 환인제약은 왜, 자사주를 '흑기사 지분'으로 바꿨나&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>명인제약 상장 vs 환인제약 승계 ‘주목’ - 데일리메디</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBXcFRGcVdJZDAxLUpxWjRVRDZIemY3ZFJfOGszNUo4QWNLamFYZTNqQm1SekdhZVBqbzAxTzB3US1QSU9hYUNWZXFhTDhkSDZQU1M0SU9Tdk5mVWVLbTFaUThsRWctbTQ1YmtCVg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBXcFRGcVdJZDAxLUpxWjRVRDZIemY3ZFJfOGszNUo4QWNLamFYZTNqQm1SekdhZVBqbzAxTzB3US1QSU9hYUNWZXFhTDhkSDZQU1M0SU9Tdk5mVWVLbTFaUThsRWctbTQ1YmtCVg</guid><pubDate>Tue, 04 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBXcFRGcVdJZDAxLUpxWjRVRDZIemY3ZFJfOGszNUo4QWNLamFYZTNqQm1SekdhZVBqbzAxTzB3US1QSU9hYUNWZXFhTDhkSDZQU1M0SU9Tdk5mVWVLbTFaUThsRWctbTQ1YmtCVg?oc=5" target="_blank"&gt;명인제약 상장 vs 환인제약 승계 ‘주목’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리메디&lt;/font&gt;</description><source url="https://dailymedi.com">데일리메디</source></item><item><title>환인제약, 1분기 영업이익 77% 급증…수익성 대폭 개선 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE53ZnNfdXI4WTlLMWdvTlo4aWY5cGhyNTNhbnRpeFBYb2VsdmdaaEFYOGwwWmwzamdGSEtyTmVhYVVwRUdNcVhhN0FlekUzS1NzM2JXT0NsZUU3TUNuOWphNFRKMERGX1lnNmUxeA?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE53ZnNfdXI4WTlLMWdvTlo4aWY5cGhyNTNhbnRpeFBYb2VsdmdaaEFYOGwwWmwzamdGSEtyTmVhYVVwRUdNcVhhN0FlekUzS1NzM2JXT0NsZUU3TUNuOWphNFRKMERGX1lnNmUxeA</guid><pubDate>Mon, 27 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE53ZnNfdXI4WTlLMWdvTlo4aWY5cGhyNTNhbnRpeFBYb2VsdmdaaEFYOGwwWmwzamdGSEtyTmVhYVVwRUdNcVhhN0FlekUzS1NzM2JXT0NsZUU3TUNuOWphNFRKMERGX1lnNmUxeA?oc=5" target="_blank"&gt;환인제약, 1분기 영업이익 77% 급증…수익성 대폭 개선&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>비피도, 254억 건물 매각…환인제약 투자 성과 주목 - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBkWHZ0QU1RUHVEZlcyUms4V0w5QW1oTGo0TlgtdG5QUlZpMHQ4eWFIMVdTQS11a2pSMlZIcHZueDI3bEFFRklyYmZrTVVIeFY0a1RZTC1Wd3AwZ3RCX0JPSG1BZUhsUHlJNmFz?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBkWHZ0QU1RUHVEZlcyUms4V0w5QW1oTGo0TlgtdG5QUlZpMHQ4eWFIMVdTQS11a2pSMlZIcHZueDI3bEFFRklyYmZrTVVIeFY0a1RZTC1Wd3AwZ3RCX0JPSG1BZUhsUHlJNmFz</guid><pubDate>Sat, 11 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBkWHZ0QU1RUHVEZlcyUms4V0w5QW1oTGo0TlgtdG5QUlZpMHQ4eWFIMVdTQS11a2pSMlZIcHZueDI3bEFFRklyYmZrTVVIeFY0a1RZTC1Wd3AwZ3RCX0JPSG1BZUhsUHlJNmFz?oc=5" target="_blank"&gt;비피도, 254억 건물 매각…환인제약 투자 성과 주목&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>환인제약, ADHD 치료제 '콘서타' 아성 정조준 생동 임상 승인 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBfNUlrS2swZkNyWHlKS2ZIMjN2UmVXSFVJbmdURVdLdURFVFgxbUxON1dZdlUyYTk3Z3dmWmtiQ3lKckpMejU4RDJEdm85N0RWTkgwQ0tQTFdwbmtRWDljZTFEOVdHNjhPdWxWOA?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBfNUlrS2swZkNyWHlKS2ZIMjN2UmVXSFVJbmdURVdLdURFVFgxbUxON1dZdlUyYTk3Z3dmWmtiQ3lKckpMejU4RDJEdm85N0RWTkgwQ0tQTFdwbmtRWDljZTFEOVdHNjhPdWxWOA</guid><pubDate>Thu, 05 Mar 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBfNUlrS2swZkNyWHlKS2ZIMjN2UmVXSFVJbmdURVdLdURFVFgxbUxON1dZdlUyYTk3Z3dmWmtiQ3lKckpMejU4RDJEdm85N0RWTkgwQ0tQTFdwbmtRWDljZTFEOVdHNjhPdWxWOA?oc=5" target="_blank"&gt;환인제약, ADHD 치료제 '콘서타' 아성 정조준 생동 임상 승인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>환인제약, 뇌전증 치료제 '브리바정' 비급여 동시 발매 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5UdXZ0QmIxOHpmOFlOUFllSUxaQjRkZ1lTOVdJWW5WVDV2Rk9ZYWN2amVzd3lXSVhOQjdhRUZvVFE3TFBkNExTbVUyN1VvYjJOa1NxaUdtem1ycFFUVHJZRWxhS2RLWlRDcFluaQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5UdXZ0QmIxOHpmOFlOUFllSUxaQjRkZ1lTOVdJWW5WVDV2Rk9ZYWN2amVzd3lXSVhOQjdhRUZvVFE3TFBkNExTbVUyN1VvYjJOa1NxaUdtem1ycFFUVHJZRWxhS2RLWlRDcFluaQ</guid><pubDate>Mon, 23 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5UdXZ0QmIxOHpmOFlOUFllSUxaQjRkZ1lTOVdJWW5WVDV2Rk9ZYWN2amVzd3lXSVhOQjdhRUZvVFE3TFBkNExTbVUyN1VvYjJOa1NxaUdtem1ycFFUVHJZRWxhS2RLWlRDcFluaQ?oc=5" target="_blank"&gt;환인제약, 뇌전증 치료제 '브리바정' 비급여 동시 발매&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>환인제약, 자사주 전략 '연쇄 연결'로 확장 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE9mQ1g3c1NmQ01FeFAzSy1SZXAtajNHY2tNejhEdG01VHNtZlV0TndHbU90S3kwWXlZUFoyM0xkU00teUhxWV9wTGdpd2RNdWtteU1ndDNDbkdxQllzN3dqTTZyb0tldFpZVHFjWA?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE9mQ1g3c1NmQ01FeFAzSy1SZXAtajNHY2tNejhEdG01VHNtZlV0TndHbU90S3kwWXlZUFoyM0xkU00teUhxWV9wTGdpd2RNdWtteU1ndDNDbkdxQllzN3dqTTZyb0tldFpZVHFjWA</guid><pubDate>Fri, 19 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9mQ1g3c1NmQ01FeFAzSy1SZXAtajNHY2tNejhEdG01VHNtZlV0TndHbU90S3kwWXlZUFoyM0xkU00teUhxWV9wTGdpd2RNdWtteU1ndDNDbkdxQllzN3dqTTZyb0tldFpZVHFjWA?oc=5" target="_blank"&gt;환인제약, 자사주 전략 '연쇄 연결'로 확장&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>유나이티드·환인·삼진까지…제약바이오 '고배당 공시' 줄잇는다 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE9hVGYxV09ZOEhqNWJxT0hNeGVYUmhIempNdEtQRmJ5a0dQdEhSMEdGOUpZRHVtTFhSNDJZVEhFV3JaT2laUnhSSFFBX1JEN2RzdmJNcHkxY3BuYW0wNVlzRTh6WjhXTG1DYjdhZg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE9hVGYxV09ZOEhqNWJxT0hNeGVYUmhIempNdEtQRmJ5a0dQdEhSMEdGOUpZRHVtTFhSNDJZVEhFV3JaT2laUnhSSFFBX1JEN2RzdmJNcHkxY3BuYW0wNVlzRTh6WjhXTG1DYjdhZg</guid><pubDate>Mon, 23 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9hVGYxV09ZOEhqNWJxT0hNeGVYUmhIempNdEtQRmJ5a0dQdEhSMEdGOUpZRHVtTFhSNDJZVEhFV3JaT2laUnhSSFFBX1JEN2RzdmJNcHkxY3BuYW0wNVlzRTh6WjhXTG1DYjdhZg?oc=5" target="_blank"&gt;유나이티드·환인·삼진까지…제약바이오 '고배당 공시' 줄잇는다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>[채용 원픽] 환인제약, 글로벌RA·RA·사업개발(~2/4) - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9ZRG5CaGkxaTVOSFBBb1hHMjN3bUhWWkwzclJQZUdwV3BqWE1TcDVuUGg3U3ZQcF9XdG45SjhVWkpRV0hhRENGMTBGTUhMVVVjRjk1YlJxb2tnNFk3ZmFOMWs3TFN3YXBnejFF?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9ZRG5CaGkxaTVOSFBBb1hHMjN3bUhWWkwzclJQZUdwV3BqWE1TcDVuUGg3U3ZQcF9XdG45SjhVWkpRV0hhRENGMTBGTUhMVVVjRjk1YlJxb2tnNFk3ZmFOMWs3TFN3YXBnejFF</guid><pubDate>Mon, 26 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9ZRG5CaGkxaTVOSFBBb1hHMjN3bUhWWkwzclJQZUdwV3BqWE1TcDVuUGg3U3ZQcF9XdG45SjhVWkpRV0hhRENGMTBGTUhMVVVjRjk1YlJxb2tnNFk3ZmFOMWs3TFN3YXBnejFF?oc=5" target="_blank"&gt;[채용 원픽] 환인제약, 글로벌RA·RA·사업개발(~2/4)&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>환인제약, 1분기 영업이익 93억8100만원… 전년 대비 77.7% 증가 - 디지털투데이</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE91YVozeWFZMG1sZ3BhS0kycERHRU1nOWkxRnUxcUxrTzhNLV9zcW5lWXVjYUpiaXBDcVpfaXJxaS1GZVhzdXJjMTE1aTRrSFJScmdMZ0RfZklZa3RralFZeXpkak5hQTBKZzVWM09ZbVpsdFk?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE91YVozeWFZMG1sZ3BhS0kycERHRU1nOWkxRnUxcUxrTzhNLV9zcW5lWXVjYUpiaXBDcVpfaXJxaS1GZVhzdXJjMTE1aTRrSFJScmdMZ0RfZklZa3RralFZeXpkak5hQTBKZzVWM09ZbVpsdFk</guid><pubDate>Mon, 27 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE91YVozeWFZMG1sZ3BhS0kycERHRU1nOWkxRnUxcUxrTzhNLV9zcW5lWXVjYUpiaXBDcVpfaXJxaS1GZVhzdXJjMTE1aTRrSFJScmdMZ0RfZklZa3RralFZeXpkak5hQTBKZzVWM09ZbVpsdFk?oc=5" target="_blank"&gt;환인제약, 1분기 영업이익 93억8100만원… 전년 대비 77.7% 증가&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;디지털투데이&lt;/font&gt;</description><source url="https://www.digitaltoday.co.kr">디지털투데이</source></item><item><title>정신과약 투톱 명인·환인제약, 영업이익률 4배 차이나는 이유 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE1GaVI5Rm5WMnJIUlJ3X2NfSlQ2VWVESm81ZG1NVWNNckNDX3VUaEJqZFJYdUt0YUZQVjhQRTVQRDVMN3NMU2t3UEhWWkZyMTE0bWZCbmVrVHZmTEgwYk1HY3hlM1ZLZzY3S1dXZ0xB?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE1GaVI5Rm5WMnJIUlJ3X2NfSlQ2VWVESm81ZG1NVWNNckNDX3VUaEJqZFJYdUt0YUZQVjhQRTVQRDVMN3NMU2t3UEhWWkZyMTE0bWZCbmVrVHZmTEgwYk1HY3hlM1ZLZzY3S1dXZ0xB</guid><pubDate>Mon, 01 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1GaVI5Rm5WMnJIUlJ3X2NfSlQ2VWVESm81ZG1NVWNNckNDX3VUaEJqZFJYdUt0YUZQVjhQRTVQRDVMN3NMU2t3UEhWWkZyMTE0bWZCbmVrVHZmTEgwYk1HY3hlM1ZLZzY3S1dXZ0xB?oc=5" target="_blank"&gt;정신과약 투톱 명인·환인제약, 영업이익률 4배 차이나는 이유&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>환인, 이익률 17.6%→5.1%…라인업 확대로 반등 모색 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiVkFVX3lxTFBvdU1hRkNhVHRSTlN3a3pLVnREcVZFNGpsY2FKUm1rdzRCZ0NfQUxXVWthZTFYTjY1WV9MSGcwekhacTEtSUltcHZYUGR6RUlvZHd2Z1B3?oc=5</link><guid isPermaLink="false">CBMiVkFVX3lxTFBvdU1hRkNhVHRSTlN3a3pLVnREcVZFNGpsY2FKUm1rdzRCZ0NfQUxXVWthZTFYTjY1WV9MSGcwekhacTEtSUltcHZYUGR6RUlvZHd2Z1B3</guid><pubDate>Thu, 19 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTFBvdU1hRkNhVHRSTlN3a3pLVnREcVZFNGpsY2FKUm1rdzRCZ0NfQUxXVWthZTFYTjY1WV9MSGcwekhacTEtSUltcHZYUGR6RUlvZHd2Z1B3?oc=5" target="_blank"&gt;환인, 이익률 17.6%→5.1%…라인업 확대로 반등 모색&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>환인제약, 동국·경동·진양과 자사주 스왑...지분 동맹 구축 - 메디코파마</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE9vYnhKNDhsa0QyX05vQ3dRdlRKUUsxeEhvS01ReHFJZF83WFdKU3JkSktleFo1WjVUMVB6TVphamNkc09STWp3dnR6NEdyUXJiYmEyYkxqQkhsSzN0Ykh5LW9obGNzQ1FaaVR5ZjRaX2ttZw?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE9vYnhKNDhsa0QyX05vQ3dRdlRKUUsxeEhvS01ReHFJZF83WFdKU3JkSktleFo1WjVUMVB6TVphamNkc09STWp3dnR6NEdyUXJiYmEyYkxqQkhsSzN0Ykh5LW9obGNzQ1FaaVR5ZjRaX2ttZw</guid><pubDate>Thu, 11 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE9vYnhKNDhsa0QyX05vQ3dRdlRKUUsxeEhvS01ReHFJZF83WFdKU3JkSktleFo1WjVUMVB6TVphamNkc09STWp3dnR6NEdyUXJiYmEyYkxqQkhsSzN0Ykh5LW9obGNzQ1FaaVR5ZjRaX2ttZw?oc=5" target="_blank"&gt;환인제약, 동국·경동·진양과 자사주 스왑...지분 동맹 구축&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디코파마&lt;/font&gt;</description><source url="https://www.medicopharma.co.kr">메디코파마</source></item><item><title>환인제약, 궤양성 대장염 치료제 토파시즈정 10mg 발매 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5CZkVDdy1vQ21Ed0NDekJvbDB3SE5kU1dNS25UaUhjdHVHUmc0YzBGRVI4VXBBc3ZybzZ1N1pBeGxBaENDMVNNQnNIVXh1UlNYam1EbWE5cV9ZX2I5TzEwaWM0c3BsVk9mUW9NYg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5CZkVDdy1vQ21Ed0NDekJvbDB3SE5kU1dNS25UaUhjdHVHUmc0YzBGRVI4VXBBc3ZybzZ1N1pBeGxBaENDMVNNQnNIVXh1UlNYam1EbWE5cV9ZX2I5TzEwaWM0c3BsVk9mUW9NYg</guid><pubDate>Mon, 02 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5CZkVDdy1vQ21Ed0NDekJvbDB3SE5kU1dNS25UaUhjdHVHUmc0YzBGRVI4VXBBc3ZybzZ1N1pBeGxBaENDMVNNQnNIVXh1UlNYam1EbWE5cV9ZX2I5TzEwaWM0c3BsVk9mUW9NYg?oc=5" target="_blank"&gt;환인제약, 궤양성 대장염 치료제 토파시즈정 10mg 발매&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>환인제약 투자분석 2026. 05. 09 - 주달</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTFA3emx0REZMTnZwbThuQk5hc3Nza0IxbE5LaTREOEp4Q1JQU1dWUnM4bzBUSGg4S2NkNTB5c1RVQnFhT1lmUDVxelYtby1SYnVRdDBwUUItSVhsbEZXRjd2M0xvR2FtRS1zU2twQzdHdDRldTg?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTFA3emx0REZMTnZwbThuQk5hc3Nza0IxbE5LaTREOEp4Q1JQU1dWUnM4bzBUSGg4S2NkNTB5c1RVQnFhT1lmUDVxelYtby1SYnVRdDBwUUItSVhsbEZXRjd2M0xvR2FtRS1zU2twQzdHdDRldTg</guid><pubDate>Sat, 09 May 2026 07:41:54 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTFA3emx0REZMTnZwbThuQk5hc3Nza0IxbE5LaTREOEp4Q1JQU1dWUnM4bzBUSGg4S2NkNTB5c1RVQnFhT1lmUDVxelYtby1SYnVRdDBwUUItSVhsbEZXRjd2M0xvR2FtRS1zU2twQzdHdDRldTg?oc=5" target="_blank"&gt;환인제약 투자분석 2026. 05. 09&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;주달&lt;/font&gt;</description><source url="https://www.judal.co.kr">주달</source></item><item><title>[경력채용] 제일약품, HK이노엔, 환인제약, 알테오젠, 대원헬스케어 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBEWXdXb2dLOFIxX2VNbE1mU1dJT1JUNlU2M3loLW0wZVBtZDJNeUJVYWdyU1dQU2c2bXpZT1RYN3lJRF9MYnB3WFZ3SHhlRFBYak5XSU9GbUY1bS1YVlpVbWVGSTloeENNRWFZ?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBEWXdXb2dLOFIxX2VNbE1mU1dJT1JUNlU2M3loLW0wZVBtZDJNeUJVYWdyU1dQU2c2bXpZT1RYN3lJRF9MYnB3WFZ3SHhlRFBYak5XSU9GbUY1bS1YVlpVbWVGSTloeENNRWFZ</guid><pubDate>Tue, 24 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBEWXdXb2dLOFIxX2VNbE1mU1dJT1JUNlU2M3loLW0wZVBtZDJNeUJVYWdyU1dQU2c2bXpZT1RYN3lJRF9MYnB3WFZ3SHhlRFBYak5XSU9GbUY1bS1YVlpVbWVGSTloeENNRWFZ?oc=5" target="_blank"&gt;[경력채용] 제일약품, HK이노엔, 환인제약, 알테오젠, 대원헬스케어&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>환인제약, ‘환인정신의학상’ 시상…명우재·김혜원 수상 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiZEFVX3lxTE1nOHl5eG1qakVSWk1SQndVZXA4VF9jVFRlQmhPNlNBUW9IM1lDcnBIeFJaZmhVSElERWcxQ1F0eG9ldktmN2k4T1g2TGdKbEY2cnFZY1hEd1JWYVJ2MEtjZVYwWkc?oc=5</link><guid isPermaLink="false">CBMiZEFVX3lxTE1nOHl5eG1qakVSWk1SQndVZXA4VF9jVFRlQmhPNlNBUW9IM1lDcnBIeFJaZmhVSElERWcxQ1F0eG9ldktmN2k4T1g2TGdKbEY2cnFZY1hEd1JWYVJ2MEtjZVYwWkc</guid><pubDate>Fri, 17 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE1nOHl5eG1qakVSWk1SQndVZXA4VF9jVFRlQmhPNlNBUW9IM1lDcnBIeFJaZmhVSElERWcxQ1F0eG9ldktmN2k4T1g2TGdKbEY2cnFZY1hEd1JWYVJ2MEtjZVYwWkc?oc=5" target="_blank"&gt;환인제약, ‘환인정신의학상’ 시상…명우재·김혜원 수상&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>환인제약, 젤잔즈 저함량 제네릭 '토파시즈정5mg' 선봬 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9zeEl0d2NyVEVnRFE0QzEzOUs4VFJCWEdGU0UxVEhLcGctV0pZNGdjNG9wM0ZBbDhiaXVGUlpvYTlSRWQwRXV0OFdiZE9iUGJZUW5KZmZsOHlZRFhGR0NJTng1QWs5MW1QZDlB?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9zeEl0d2NyVEVnRFE0QzEzOUs4VFJCWEdGU0UxVEhLcGctV0pZNGdjNG9wM0ZBbDhiaXVGUlpvYTlSRWQwRXV0OFdiZE9iUGJZUW5KZmZsOHlZRFhGR0NJTng1QWs5MW1QZDlB</guid><pubDate>Mon, 24 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9zeEl0d2NyVEVnRFE0QzEzOUs4VFJCWEdGU0UxVEhLcGctV0pZNGdjNG9wM0ZBbDhiaXVGUlpvYTlSRWQwRXV0OFdiZE9iUGJZUW5KZmZsOHlZRFhGR0NJTng1QWs5MW1QZDlB?oc=5" target="_blank"&gt;환인제약, 젤잔즈 저함량 제네릭 '토파시즈정5mg' 선봬&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>환인제약, 학술상 등 제28회 환인정신의학상 시상 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTFBJd1BDU2dSWXRaYkpFVFNKWlNFcWMzT3JOUnh5cU5xTU43Ylo2MlpsdEsyTHJXamtlMHpkNy1VM3ROVUdCY2NpeEllN2g4MTZtMm4wZnpjNEdhTnF1NTFzcy1sRTFHNHZfZXk5T1dKTmdLZVE?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTFBJd1BDU2dSWXRaYkpFVFNKWlNFcWMzT3JOUnh5cU5xTU43Ylo2MlpsdEsyTHJXamtlMHpkNy1VM3ROVUdCY2NpeEllN2g4MTZtMm4wZnpjNEdhTnF1NTFzcy1sRTFHNHZfZXk5T1dKTmdLZVE</guid><pubDate>Fri, 17 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTFBJd1BDU2dSWXRaYkpFVFNKWlNFcWMzT3JOUnh5cU5xTU43Ylo2MlpsdEsyTHJXamtlMHpkNy1VM3ROVUdCY2NpeEllN2g4MTZtMm4wZnpjNEdhTnF1NTFzcy1sRTFHNHZfZXk5T1dKTmdLZVE?oc=5" target="_blank"&gt;환인제약, 학술상 등 제28회 환인정신의학상 시상&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>환인제약 "ADHD 치료제 시장 공략" - 데일리메디</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTFBPb1ZzTFRKSUJ4Tk5za2piaGZDaHdWTzk0RENpQVU1RXRlX0pzeHkyeTlQcG5oY0hBaTlmbl92VlBFZVllR2FhTHlZM1hJcEdWVEEtRE5nakZ3T0lBT1Z1ampkbXVRZEpy?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTFBPb1ZzTFRKSUJ4Tk5za2piaGZDaHdWTzk0RENpQVU1RXRlX0pzeHkyeTlQcG5oY0hBaTlmbl92VlBFZVllR2FhTHlZM1hJcEdWVEEtRE5nakZ3T0lBT1Z1ampkbXVRZEpy</guid><pubDate>Fri, 31 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTFBPb1ZzTFRKSUJ4Tk5za2piaGZDaHdWTzk0RENpQVU1RXRlX0pzeHkyeTlQcG5oY0hBaTlmbl92VlBFZVllR2FhTHlZM1hJcEdWVEEtRE5nakZ3T0lBT1Z1ampkbXVRZEpy?oc=5" target="_blank"&gt;환인제약 "ADHD 치료제 시장 공략"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리메디&lt;/font&gt;</description><source url="https://www.dailymedi.com">데일리메디</source></item><item><title>환인제약 2세 승계 마무리, 이광식 창업주 186만주 증여 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5Ec2w4OHJFRjN6UXh5WlBzTFNySWJ5Qk0xaENsMHJ4cXdpUGgtUDRUTU5PcFFUZ3lTZzFWVE1PU2VfbEdhTWxpZmtYSml4YnloVkhiLWpSbk5oQ09nWVUxZEd3ZjhiRWpWeFdZ?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5Ec2w4OHJFRjN6UXh5WlBzTFNySWJ5Qk0xaENsMHJ4cXdpUGgtUDRUTU5PcFFUZ3lTZzFWVE1PU2VfbEdhTWxpZmtYSml4YnloVkhiLWpSbk5oQ09nWVUxZEd3ZjhiRWpWeFdZ</guid><pubDate>Thu, 30 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5Ec2w4OHJFRjN6UXh5WlBzTFNySWJ5Qk0xaENsMHJ4cXdpUGgtUDRUTU5PcFFUZ3lTZzFWVE1PU2VfbEdhTWxpZmtYSml4YnloVkhiLWpSbk5oQ09nWVUxZEd3ZjhiRWpWeFdZ?oc=5" target="_blank"&gt;환인제약 2세 승계 마무리, 이광식 창업주 186만주 증여&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>환인제약, 제 28회 정신의학상 시상 - 한국의약통신</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1JUEtCd2hGRXotMkpKLUxOT0JadGM5dUhqQm1BeTFRNnYxVmJtT1FmWjVPSkFjaFF1WWVZa2ZWSlh1ZE9TQWs5TjJGbGI4STd5U1h2V1hRTXhPZ1dVSDFmdWprWGRPRGdVN2JJ?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1JUEtCd2hGRXotMkpKLUxOT0JadGM5dUhqQm1BeTFRNnYxVmJtT1FmWjVPSkFjaFF1WWVZa2ZWSlh1ZE9TQWs5TjJGbGI4STd5U1h2V1hRTXhPZ1dVSDFmdWprWGRPRGdVN2JJ</guid><pubDate>Fri, 17 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1JUEtCd2hGRXotMkpKLUxOT0JadGM5dUhqQm1BeTFRNnYxVmJtT1FmWjVPSkFjaFF1WWVZa2ZWSlh1ZE9TQWs5TjJGbGI4STd5U1h2V1hRTXhPZ1dVSDFmdWprWGRPRGdVN2JJ?oc=5" target="_blank"&gt;환인제약, 제 28회 정신의학상 시상&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국의약통신&lt;/font&gt;</description><source url="https://www.kmpnews.co.kr">한국의약통신</source></item><item><title>환인제약, 이원범 대표 중심 ‘2세 경영’ 본격화 - 데일리메디</title><link>https://news.google.com/rss/articles/CBMidEFVX3lxTE84dVNyS3pjam5QQUVsM2c5bTZQOGdBTFJMQjhyTVFjRmZOOXMtem1hZVB4UjZBZi1xeWplbVJjeEdLT012OUJrWm1oanZCd2hmQUtNQm4zRFJkd3EzblRsNU5faEJ3UWdjZXpuaERLaTNvZ1Jy?oc=5</link><guid isPermaLink="false">CBMidEFVX3lxTE84dVNyS3pjam5QQUVsM2c5bTZQOGdBTFJMQjhyTVFjRmZOOXMtem1hZVB4UjZBZi1xeWplbVJjeEdLT012OUJrWm1oanZCd2hmQUtNQm4zRFJkd3EzblRsNU5faEJ3UWdjZXpuaERLaTNvZ1Jy</guid><pubDate>Mon, 27 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE84dVNyS3pjam5QQUVsM2c5bTZQOGdBTFJMQjhyTVFjRmZOOXMtem1hZVB4UjZBZi1xeWplbVJjeEdLT012OUJrWm1oanZCd2hmQUtNQm4zRFJkd3EzblRsNU5faEJ3UWdjZXpuaERLaTNvZ1Jy?oc=5" target="_blank"&gt;환인제약, 이원범 대표 중심 ‘2세 경영’ 본격화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리메디&lt;/font&gt;</description><source url="https://www.dailymedi.com">데일리메디</source></item><item><title>환인제약, 제약사 3곳과 자사주 맞교환 - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE82Qkd4S3FHTUZ0NVdEcDJMN1FjdVNBYXgxRnZzU0NERXhqbV96TDFRMWFwQ3dlQURlQUE2SjBBSVRIZXFVNDhlel9vLVhleTBaeVhtYlpLNXkwZ9IBVEFVX3lxTE5ZTTZGOXFNRmNYampkUzhmNUQ3ZWpKaXM2SjI2ejUyVkhQSUdrOTEtNm5Uc18xakFXeFBLTDgwVV9CMktxaG9JSmNQLTROWlNvb2F5Ng?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE82Qkd4S3FHTUZ0NVdEcDJMN1FjdVNBYXgxRnZzU0NERXhqbV96TDFRMWFwQ3dlQURlQUE2SjBBSVRIZXFVNDhlel9vLVhleTBaeVhtYlpLNXkwZ9IBVEFVX3lxTE5ZTTZGOXFNRmNYampkUzhmNUQ3ZWpKaXM2SjI2ejUyVkhQSUdrOTEtNm5Uc18xakFXeFBLTDgwVV9CMktxaG9JSmNQLTROWlNvb2F5Ng</guid><pubDate>Fri, 12 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE82Qkd4S3FHTUZ0NVdEcDJMN1FjdVNBYXgxRnZzU0NERXhqbV96TDFRMWFwQ3dlQURlQUE2SjBBSVRIZXFVNDhlel9vLVhleTBaeVhtYlpLNXkwZ9IBVEFVX3lxTE5ZTTZGOXFNRmNYampkUzhmNUQ3ZWpKaXM2SjI2ejUyVkhQSUdrOTEtNm5Uc18xakFXeFBLTDgwVV9CMktxaG9JSmNQLTROWlNvb2F5Ng?oc=5" target="_blank"&gt;환인제약, 제약사 3곳과 자사주 맞교환&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>환인제약 3Q 매출 657억원…전년비 3.5% 감소 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5kaU5CWG4xaHRmS3B4OUdIWFFmOGN6WE56M040czJ5V280cThRT09pLU9qVC0xTTdwV0Q1Yi1ZLThmMGxKQzB0TzlBd204OGxac2ZHYzZCaDZzSU1VWDhQVlFzc2RGc2R6Q0lr?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5kaU5CWG4xaHRmS3B4OUdIWFFmOGN6WE56M040czJ5V280cThRT09pLU9qVC0xTTdwV0Q1Yi1ZLThmMGxKQzB0TzlBd204OGxac2ZHYzZCaDZzSU1VWDhQVlFzc2RGc2R6Q0lr</guid><pubDate>Fri, 31 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5kaU5CWG4xaHRmS3B4OUdIWFFmOGN6WE56M040czJ5V280cThRT09pLU9qVC0xTTdwV0Q1Yi1ZLThmMGxKQzB0TzlBd204OGxac2ZHYzZCaDZzSU1VWDhQVlFzc2RGc2R6Q0lr?oc=5" target="_blank"&gt;환인제약 3Q 매출 657억원…전년비 3.5% 감소&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>환인제약, 대만 ANXO사와 ADHD 치료제 독점개발·공급계약 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE4zVHRHYUlib2JiVW45QkMwNnoxcENIWlo2QzVYRXZYOGVzc09GZFdjaUQ2MHNQTGRpTFhTWEh2RHpuMHpTM0lxUHQxN3VfMFU2cGtzOGpIZE03QUlaMnN3WDZaQXZkYUNoZjA0?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE4zVHRHYUlib2JiVW45QkMwNnoxcENIWlo2QzVYRXZYOGVzc09GZFdjaUQ2MHNQTGRpTFhTWEh2RHpuMHpTM0lxUHQxN3VfMFU2cGtzOGpIZE03QUlaMnN3WDZaQXZkYUNoZjA0</guid><pubDate>Thu, 30 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE4zVHRHYUlib2JiVW45QkMwNnoxcENIWlo2QzVYRXZYOGVzc09GZFdjaUQ2MHNQTGRpTFhTWEh2RHpuMHpTM0lxUHQxN3VfMFU2cGtzOGpIZE03QUlaMnN3WDZaQXZkYUNoZjA0?oc=5" target="_blank"&gt;환인제약, 대만 ANXO사와 ADHD 치료제 독점개발·공급계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>중견 3사 전략축, 환인제약으로…CNS 강자에 지분 러브콜 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiUEFVX3lxTFBZWkxpcVM2VmhtUTI3M1NILWI0OXAyMVFBM1RKUTMyLXc4U1JiZXNUZkp3bHlNb0RNVzBDQjBJSzgwODhsLWQxNE54UnBFUEc1?oc=5</link><guid isPermaLink="false">CBMiUEFVX3lxTFBZWkxpcVM2VmhtUTI3M1NILWI0OXAyMVFBM1RKUTMyLXc4U1JiZXNUZkp3bHlNb0RNVzBDQjBJSzgwODhsLWQxNE54UnBFUEc1</guid><pubDate>Fri, 12 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFBZWkxpcVM2VmhtUTI3M1NILWI0OXAyMVFBM1RKUTMyLXc4U1JiZXNUZkp3bHlNb0RNVzBDQjBJSzgwODhsLWQxNE54UnBFUEc1?oc=5" target="_blank"&gt;중견 3사 전략축, 환인제약으로…CNS 강자에 지분 러브콜&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>‘CNS 명가’ 환인제약, P-CAB 시장 ‘깜짝’ 등판 … 독자 물질 확보해 개발 추진 - 헬스코리아뉴스</title><link>https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1ZdllxV1lMS2RfVlc2b1RrRXIydk9aVjFRR3UzTDMzd3hoUEpvSG1XLXJTc3BhWlZRdXFIckpIelQ0NjEzcG9sekppRDFwMGZBNEtaZ1NUQ29OaTFRc2xkV1hTbkQ1R2M?oc=5</link><guid isPermaLink="false">CBMiZ0FVX3lxTE1ZdllxV1lMS2RfVlc2b1RrRXIydk9aVjFRR3UzTDMzd3hoUEpvSG1XLXJTc3BhWlZRdXFIckpIelQ0NjEzcG9sekppRDFwMGZBNEtaZ1NUQ29OaTFRc2xkV1hTbkQ1R2M</guid><pubDate>Wed, 21 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1ZdllxV1lMS2RfVlc2b1RrRXIydk9aVjFRR3UzTDMzd3hoUEpvSG1XLXJTc3BhWlZRdXFIckpIelQ0NjEzcG9sekppRDFwMGZBNEtaZ1NUQ29OaTFRc2xkV1hTbkQ1R2M?oc=5" target="_blank"&gt;‘CNS 명가’ 환인제약, P-CAB 시장 ‘깜짝’ 등판 … 독자 물질 확보해 개발 추진&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;헬스코리아뉴스&lt;/font&gt;</description><source url="https://www.hkn24.com">헬스코리아뉴스</source></item><item><title>환인제약, ‘토파시즈정10mg’ 발매 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE1JcXluSmt1S2hSUXlDU2RkSThXR3dXM0dhbm9BV1V2aEpXMTNkZlRHVFhUQV9DRUlaMHBZVFVLVVFPTXpwSXVxM3dZRW1pMENPR0JrbDFvU0VyN2dKQ2ZzeFJZcEZUbFdOZHc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE1JcXluSmt1S2hSUXlDU2RkSThXR3dXM0dhbm9BV1V2aEpXMTNkZlRHVFhUQV9DRUlaMHBZVFVLVVFPTXpwSXVxM3dZRW1pMENPR0JrbDFvU0VyN2dKQ2ZzeFJZcEZUbFdOZHc</guid><pubDate>Mon, 02 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE1JcXluSmt1S2hSUXlDU2RkSThXR3dXM0dhbm9BV1V2aEpXMTNkZlRHVFhUQV9DRUlaMHBZVFVLVVFPTXpwSXVxM3dZRW1pMENPR0JrbDFvU0VyN2dKQ2ZzeFJZcEZUbFdOZHc?oc=5" target="_blank"&gt;환인제약, ‘토파시즈정10mg’ 발매&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>환인제약, 뇌전증 치료제 ‘브리바정’ 발매 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE5DS28wTzlRcm5UVV9NZ28tcW5hWmgtT3JNTkQxMzVJUHdyRE9GOXI1VnQ4dmt0cFNqU3FjU3RCemcxUVRJblExeVc2MFl0cFRDS004cl85OWZRNy1WQTQ3QTA0RmhsaEZEWEE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE5DS28wTzlRcm5UVV9NZ28tcW5hWmgtT3JNTkQxMzVJUHdyRE9GOXI1VnQ4dmt0cFNqU3FjU3RCemcxUVRJblExeVc2MFl0cFRDS004cl85OWZRNy1WQTQ3QTA0RmhsaEZEWEE</guid><pubDate>Mon, 23 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5DS28wTzlRcm5UVV9NZ28tcW5hWmgtT3JNTkQxMzVJUHdyRE9GOXI1VnQ4dmt0cFNqU3FjU3RCemcxUVRJblExeVc2MFl0cFRDS004cl85OWZRNy1WQTQ3QTA0RmhsaEZEWEE?oc=5" target="_blank"&gt;환인제약, 뇌전증 치료제 ‘브리바정’ 발매&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>[제약 Weekly] 유나이티드제약-환인제약, 주식 맞교환 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE5JZXJ6SnZ1Y2RRTHJHTUNVOUo3OTc5OWlaNUdxVDZwY0MzQWtEYlZJb1FYRVRlZEQxb0ZCbkhxQnU0T3QxTVV2aWZWQl9WYUNVZDY3bWdpSFpWcm1BckVOTGZ0bnI5U1U2cFE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE5JZXJ6SnZ1Y2RRTHJHTUNVOUo3OTc5OWlaNUdxVDZwY0MzQWtEYlZJb1FYRVRlZEQxb0ZCbkhxQnU0T3QxTVV2aWZWQl9WYUNVZDY3bWdpSFpWcm1BckVOTGZ0bnI5U1U2cFE</guid><pubDate>Mon, 22 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5JZXJ6SnZ1Y2RRTHJHTUNVOUo3OTc5OWlaNUdxVDZwY0MzQWtEYlZJb1FYRVRlZEQxb0ZCbkhxQnU0T3QxTVV2aWZWQl9WYUNVZDY3bWdpSFpWcm1BckVOTGZ0bnI5U1U2cFE?oc=5" target="_blank"&gt;[제약 Weekly] 유나이티드제약-환인제약, 주식 맞교환&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>환인제약, ‘브리비액트’ 제네릭 시장 독자노선 구축 ... 국내 없는 75mg 확보 - 헬스코리아뉴스</title><link>https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9xMU1TUC1GU1g0cm9PU2VBRjhYM2I4a290V2NwR1lBX3ZaeVVtcmgycHBtWkxFekNzTDV0a09KeEkyQ29tQkpRSnlSb3NtZFhTNlJqRU1qMjduVzBwc0pBX0ZnazNRNWc?oc=5</link><guid isPermaLink="false">CBMiZ0FVX3lxTE9xMU1TUC1GU1g0cm9PU2VBRjhYM2I4a290V2NwR1lBX3ZaeVVtcmgycHBtWkxFekNzTDV0a09KeEkyQ29tQkpRSnlSb3NtZFhTNlJqRU1qMjduVzBwc0pBX0ZnazNRNWc</guid><pubDate>Thu, 13 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9xMU1TUC1GU1g0cm9PU2VBRjhYM2I4a290V2NwR1lBX3ZaeVVtcmgycHBtWkxFekNzTDV0a09KeEkyQ29tQkpRSnlSb3NtZFhTNlJqRU1qMjduVzBwc0pBX0ZnazNRNWc?oc=5" target="_blank"&gt;환인제약, ‘브리비액트’ 제네릭 시장 독자노선 구축 ... 국내 없는 75mg 확보&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;헬스코리아뉴스&lt;/font&gt;</description><source url="https://www.hkn24.com">헬스코리아뉴스</source></item><item><title>비피도 성장-애즈유 주춤…환인제약 사업다각화 실적 교차 - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1OZWtuSHFiNUQxNDdIMkgwOGVLc04zcVlVVXpCbWR1LWF4V0s5OFhjbFRTTEFwTXJMTzM0WC04NXRoOTNjWkZERC1nOHZKaDF6WHBjbElwcmtnZFRqcWRFdUtVSC13cnNDaVNz?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1OZWtuSHFiNUQxNDdIMkgwOGVLc04zcVlVVXpCbWR1LWF4V0s5OFhjbFRTTEFwTXJMTzM0WC04NXRoOTNjWkZERC1nOHZKaDF6WHBjbElwcmtnZFRqcWRFdUtVSC13cnNDaVNz</guid><pubDate>Thu, 27 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1OZWtuSHFiNUQxNDdIMkgwOGVLc04zcVlVVXpCbWR1LWF4V0s5OFhjbFRTTEFwTXJMTzM0WC04NXRoOTNjWkZERC1nOHZKaDF6WHBjbElwcmtnZFRqcWRFdUtVSC13cnNDaVNz?oc=5" target="_blank"&gt;비피도 성장-애즈유 주춤…환인제약 사업다각화 실적 교차&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>환인, ADHD치료제 아토목세틴 첫 정제 선보여…경쟁력 강화 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiVkFVX3lxTE1CQk9Pdm9IeXZxeFo3VWNpQzh6VGhYdE9mdTlxNnhiN3BxM3dZblZtd19HYmdtaWs4NmJrakNYaXEwWDZ1blBybUc5Ulg3c1c3TGdTNG1n?oc=5</link><guid isPermaLink="false">CBMiVkFVX3lxTE1CQk9Pdm9IeXZxeFo3VWNpQzh6VGhYdE9mdTlxNnhiN3BxM3dZblZtd19HYmdtaWs4NmJrakNYaXEwWDZ1blBybUc5Ulg3c1c3TGdTNG1n</guid><pubDate>Sat, 10 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE1CQk9Pdm9IeXZxeFo3VWNpQzh6VGhYdE9mdTlxNnhiN3BxM3dZblZtd19HYmdtaWs4NmJrakNYaXEwWDZ1blBybUc5Ulg3c1c3TGdTNG1n?oc=5" target="_blank"&gt;환인, ADHD치료제 아토목세틴 첫 정제 선보여…경쟁력 강화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>환인제약, 제약업계 자사주 처분 '중심세력' 부각 - 딜사이트</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE1TakZSa0ozVnBfMDd5dEpudUJjMFdONW9PM254OGFodXk3Mk1ZbFRBNkhfejVxcENYRGVKdDFJbFJ0ZjU5ejd5QVNjVkkyWjg?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE1TakZSa0ozVnBfMDd5dEpudUJjMFdONW9PM254OGFodXk3Mk1ZbFRBNkhfejVxcENYRGVKdDFJbFJ0ZjU5ejd5QVNjVkkyWjg</guid><pubDate>Tue, 16 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE1TakZSa0ozVnBfMDd5dEpudUJjMFdONW9PM254OGFodXk3Mk1ZbFRBNkhfejVxcENYRGVKdDFJbFJ0ZjU5ejd5QVNjVkkyWjg?oc=5" target="_blank"&gt;환인제약, 제약업계 자사주 처분 '중심세력' 부각&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;딜사이트&lt;/font&gt;</description><source url="https://dealsite.co.kr">딜사이트</source></item><item><title>환인제약, 제28회 환인정신의학상 시상 - 메디포뉴스</title><link>https://news.google.com/rss/articles/CBMiZEFVX3lxTE1tdUhvVlBwNU1KTFZRcVdqbFpfWGVqOW9JTVF4MC11NWZ4em16azcwQ3RUN3ZwcmpvY1pDZ0t1THpTT2NPTFEyajdqT2J1X2ZmWnR3QXFqTTA5SkJ4QXpUd3c4cWI?oc=5</link><guid isPermaLink="false">CBMiZEFVX3lxTE1tdUhvVlBwNU1KTFZRcVdqbFpfWGVqOW9JTVF4MC11NWZ4em16azcwQ3RUN3ZwcmpvY1pDZ0t1THpTT2NPTFEyajdqT2J1X2ZmWnR3QXFqTTA5SkJ4QXpUd3c4cWI</guid><pubDate>Fri, 17 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE1tdUhvVlBwNU1KTFZRcVdqbFpfWGVqOW9JTVF4MC11NWZ4em16azcwQ3RUN3ZwcmpvY1pDZ0t1THpTT2NPTFEyajdqT2J1X2ZmWnR3QXFqTTA5SkJ4QXpUd3c4cWI?oc=5" target="_blank"&gt;환인제약, 제28회 환인정신의학상 시상&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디포뉴스&lt;/font&gt;</description><source url="https://www.medifonews.com">메디포뉴스</source></item><item><title>명우제 교수와 김혜원 교수 환인정신의학상 수상 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFA3RFkwaGozNDlwZVhqNVdRRTFrRnh1bzVQalBIS1dlZDBGRjhaRVU1MkJKcmdpOVBiZFVQeEdveV9zZFZ0NUxPaTNSSjRaZlNIYzNhd3QyOUhJZDhhZU8zYXZyZ3dRWng5cWxV?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFA3RFkwaGozNDlwZVhqNVdRRTFrRnh1bzVQalBIS1dlZDBGRjhaRVU1MkJKcmdpOVBiZFVQeEdveV9zZFZ0NUxPaTNSSjRaZlNIYzNhd3QyOUhJZDhhZU8zYXZyZ3dRWng5cWxV</guid><pubDate>Fri, 17 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFA3RFkwaGozNDlwZVhqNVdRRTFrRnh1bzVQalBIS1dlZDBGRjhaRVU1MkJKcmdpOVBiZFVQeEdveV9zZFZ0NUxPaTNSSjRaZlNIYzNhd3QyOUhJZDhhZU8zYXZyZ3dRWng5cWxV?oc=5" target="_blank"&gt;명우제 교수와 김혜원 교수 환인정신의학상 수상&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>환인제약 2세 경영체제 공식화, 중장기 성장 기반 재정비 - 의약뉴스</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE9ncnVYQURjaGpJQzl6TWc5MHhJNEpfZnctRnR2VlAwWGtIVzIxTmVzNk8yaWVDWUJBbUw1bW5TUFZSVUtkVnZkZ0NYOFNSTmU0eGlBS3hkWHVObDEtbFRXZlo3Z3VyYmVr?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE9ncnVYQURjaGpJQzl6TWc5MHhJNEpfZnctRnR2VlAwWGtIVzIxTmVzNk8yaWVDWUJBbUw1bW5TUFZSVUtkVnZkZ0NYOFNSTmU0eGlBS3hkWHVObDEtbFRXZlo3Z3VyYmVr</guid><pubDate>Fri, 07 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE9ncnVYQURjaGpJQzl6TWc5MHhJNEpfZnctRnR2VlAwWGtIVzIxTmVzNk8yaWVDWUJBbUw1bW5TUFZSVUtkVnZkZ0NYOFNSTmU0eGlBS3hkWHVObDEtbFRXZlo3Z3VyYmVr?oc=5" target="_blank"&gt;환인제약 2세 경영체제 공식화, 중장기 성장 기반 재정비&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의약뉴스&lt;/font&gt;</description><source url="https://www.newsmp.com">의약뉴스</source></item><item><title>[경력채용] 제일약품, 환인제약, 안국약품, 유바이오로직스, 메디톡스 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBnelVKZ2djMWJPYlBuNmV3WTFRd0dKTHZqSjItN25JaFNLTnRtaUdITzNrYlFlclNEQjRLRHF4c0ZzTUIzN2NvTW5mc2U1TkY0S3R5UmtBRnFGbXRVdjFyWHFzOXBRU2txT01Z?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBnelVKZ2djMWJPYlBuNmV3WTFRd0dKTHZqSjItN25JaFNLTnRtaUdITzNrYlFlclNEQjRLRHF4c0ZzTUIzN2NvTW5mc2U1TkY0S3R5UmtBRnFGbXRVdjFyWHFzOXBRU2txT01Z</guid><pubDate>Fri, 23 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBnelVKZ2djMWJPYlBuNmV3WTFRd0dKTHZqSjItN25JaFNLTnRtaUdITzNrYlFlclNEQjRLRHF4c0ZzTUIzN2NvTW5mc2U1TkY0S3R5UmtBRnFGbXRVdjFyWHFzOXBRU2txT01Z?oc=5" target="_blank"&gt;[경력채용] 제일약품, 환인제약, 안국약품, 유바이오로직스, 메디톡스&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>환인제약, 지난해 영업이익 130억1853만2000원… 전년 대비 39.4% 감소 - 디지털투데이</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE5CY21odVROSFFpYTI2d0M4ZnlxckFEVXc3UERkUVg3cml2ZjJtc3ZpeFVJZm5iMVB4MGtpMFZ5Wm5BMjVRcFR4RmpzemwwZHV5eV84UkpKdkdZXzdFVEpjVHh3LXQ2YXJON2JwUk1GeHZZSTQ?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE5CY21odVROSFFpYTI2d0M4ZnlxckFEVXc3UERkUVg3cml2ZjJtc3ZpeFVJZm5iMVB4MGtpMFZ5Wm5BMjVRcFR4RmpzemwwZHV5eV84UkpKdkdZXzdFVEpjVHh3LXQ2YXJON2JwUk1GeHZZSTQ</guid><pubDate>Fri, 13 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE5CY21odVROSFFpYTI2d0M4ZnlxckFEVXc3UERkUVg3cml2ZjJtc3ZpeFVJZm5iMVB4MGtpMFZ5Wm5BMjVRcFR4RmpzemwwZHV5eV84UkpKdkdZXzdFVEpjVHh3LXQ2YXJON2JwUk1GeHZZSTQ?oc=5" target="_blank"&gt;환인제약, 지난해 영업이익 130억1853만2000원… 전년 대비 39.4% 감소&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;디지털투데이&lt;/font&gt;</description><source url="https://www.digitaltoday.co.kr">디지털투데이</source></item><item><title>환인제약, 뇌전증 치료제 '브리바정' 5개 함량 동시 발매 - MEDI:GATE NEWS</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTFBmaVQ2alB6bVJpbjByRWpwTHYxTjBQREdfU3NISWlPMWsxOTZYN2tDMlAwNkVBOV9SLU9FVFpHd3Fhc2NyUlhGaGsyRFdUWG1iMGNEbE9oMA?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTFBmaVQ2alB6bVJpbjByRWpwTHYxTjBQREdfU3NISWlPMWsxOTZYN2tDMlAwNkVBOV9SLU9FVFpHd3Fhc2NyUlhGaGsyRFdUWG1iMGNEbE9oMA</guid><pubDate>Wed, 25 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFBmaVQ2alB6bVJpbjByRWpwTHYxTjBQREdfU3NISWlPMWsxOTZYN2tDMlAwNkVBOV9SLU9FVFpHd3Fhc2NyUlhGaGsyRFdUWG1iMGNEbE9oMA?oc=5" target="_blank"&gt;환인제약, 뇌전증 치료제 '브리바정' 5개 함량 동시 발매&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;MEDI:GATE NEWS&lt;/font&gt;</description><source url="https://www.medigatenews.com">MEDI:GATE NEWS</source></item><item><title>환인제약 애즈유, 라우드코퍼레이션과 파트너십 체결 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBkRWRJVDRsTm82d1dFWXVPYWlmRUM3TFZsTjJ3SU5uV19Ic0tfX1ZfQTd1X3RxaEFoTGs3REt2OTIyOUt6TmVsYXVTSkFrT2J6WkZGbnZCalRjcy15X3VXYWt2MmFYWlFGZ0Nj?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBkRWRJVDRsTm82d1dFWXVPYWlmRUM3TFZsTjJ3SU5uV19Ic0tfX1ZfQTd1X3RxaEFoTGs3REt2OTIyOUt6TmVsYXVTSkFrT2J6WkZGbnZCalRjcy15X3VXYWt2MmFYWlFGZ0Nj</guid><pubDate>Thu, 23 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBkRWRJVDRsTm82d1dFWXVPYWlmRUM3TFZsTjJ3SU5uV19Ic0tfX1ZfQTd1X3RxaEFoTGs3REt2OTIyOUt6TmVsYXVTSkFrT2J6WkZGbnZCalRjcy15X3VXYWt2MmFYWlFGZ0Nj?oc=5" target="_blank"&gt;환인제약 애즈유, 라우드코퍼레이션과 파트너십 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>환인제약, 궤양성 대장염 치료제 '토파시즈정10mg' 출시 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE41V0M0U1VQa215S1NtdEtjaUxmNDNISTRjNktmcjg1alJadjB2MVoxVWducTgyenBmNlJWdGRFZGx0dno3NmlHMDNrZFF5cHNsakx3QmR6cjdTZEx1MUFCaUFXT2RsUGI1MGV3?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE41V0M0U1VQa215S1NtdEtjaUxmNDNISTRjNktmcjg1alJadjB2MVoxVWducTgyenBmNlJWdGRFZGx0dno3NmlHMDNrZFF5cHNsakx3QmR6cjdTZEx1MUFCaUFXT2RsUGI1MGV3</guid><pubDate>Mon, 02 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE41V0M0U1VQa215S1NtdEtjaUxmNDNISTRjNktmcjg1alJadjB2MVoxVWducTgyenBmNlJWdGRFZGx0dno3NmlHMDNrZFF5cHNsakx3QmR6cjdTZEx1MUFCaUFXT2RsUGI1MGV3?oc=5" target="_blank"&gt;환인제약, 궤양성 대장염 치료제 '토파시즈정10mg' 출시&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>[버핏 리포트] 환인제약, 올해 수익성 회복 기대감 존재...기업가치 제고 계획 발표 - LS - 버핏연구소</title><link>https://news.google.com/rss/articles/CBMiYkFVX3lxTFBvaTdmN2E0eTBQcW84TVBvMHpkWmZRSFRTNjk3U256Z1ZZeTNBV1FyczRINjJ3NDFZUFhDNVpubU13NTBYWlFFdmwwNkdKYkk3LVlURXlORml3X3loVGZSNENR?oc=5</link><guid isPermaLink="false">CBMiYkFVX3lxTFBvaTdmN2E0eTBQcW84TVBvMHpkWmZRSFRTNjk3U256Z1ZZeTNBV1FyczRINjJ3NDFZUFhDNVpubU13NTBYWlFFdmwwNkdKYkk3LVlURXlORml3X3loVGZSNENR</guid><pubDate>Tue, 24 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTFBvaTdmN2E0eTBQcW84TVBvMHpkWmZRSFRTNjk3U256Z1ZZeTNBV1FyczRINjJ3NDFZUFhDNVpubU13NTBYWlFFdmwwNkdKYkk3LVlURXlORml3X3loVGZSNENR?oc=5" target="_blank"&gt;[버핏 리포트] 환인제약, 올해 수익성 회복 기대감 존재...기업가치 제고 계획 발표 - LS&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;버핏연구소&lt;/font&gt;</description><source url="https://www.buffettlab.co.kr">버핏연구소</source></item><item><title>﻿환인제약, 듀카포지정 30/2.5mg 저용량 추가 발매 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE1UVGhpbDJRRmEyamFYUXBtU2tfNGtaYUh6aEFtYXNKczJPRHhmcVNRM2VPRlh2R251aEtSLXkyaHlmZXJabDJySmwtNHE5dmoydkhkc3RieU1aS2hUbExfV3Rab3QyMjJVNHhWSGZn?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE1UVGhpbDJRRmEyamFYUXBtU2tfNGtaYUh6aEFtYXNKczJPRHhmcVNRM2VPRlh2R251aEtSLXkyaHlmZXJabDJySmwtNHE5dmoydkhkc3RieU1aS2hUbExfV3Rab3QyMjJVNHhWSGZn</guid><pubDate>Tue, 30 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1UVGhpbDJRRmEyamFYUXBtU2tfNGtaYUh6aEFtYXNKczJPRHhmcVNRM2VPRlh2R251aEtSLXkyaHlmZXJabDJySmwtNHE5dmoydkhkc3RieU1aS2hUbExfV3Rab3QyMjJVNHhWSGZn?oc=5" target="_blank"&gt;﻿환인제약, 듀카포지정 30/2.5mg 저용량 추가 발매&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>[거버넌스워치] 환인제약 이광식 200억 주식증여…2대 세습 매듭 수순 - v.daum.net</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE0zQlJnWXNQYjlFU1ZGNjZ3bDBkNE5EZ3RtSW1ZU2FrQXRwQVFncktNUGVNOFBVWlV1TXo0ZEx3Y0UtbVg0RzNHTlF2VUpoRlk?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE0zQlJnWXNQYjlFU1ZGNjZ3bDBkNE5EZ3RtSW1ZU2FrQXRwQVFncktNUGVNOFBVWlV1TXo0ZEx3Y0UtbVg0RzNHTlF2VUpoRlk</guid><pubDate>Wed, 22 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE0zQlJnWXNQYjlFU1ZGNjZ3bDBkNE5EZ3RtSW1ZU2FrQXRwQVFncktNUGVNOFBVWlV1TXo0ZEx3Y0UtbVg0RzNHTlF2VUpoRlk?oc=5" target="_blank"&gt;[거버넌스워치] 환인제약 이광식 200억 주식증여…2대 세습 매듭 수순&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;v.daum.net&lt;/font&gt;</description><source url="https://v.daum.net">v.daum.net</source></item><item><title>'라투다' 성장세에 환인제약 이어 명인제약도 특허 도전장 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE1aQzJWTGpuSVNMdXV2cjk5QUZWeUp3eWc1Z3E2MG9GcWhpVUF4MGt2ekFWMHpxTDFHeDdYUGVVVmZjZ0h4N1BJQ3p6ZzdCRlJBYjduc29uX0tmLTlOTDhGQUJpVlZUMHpGVGVoemN4cHhwMnM?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE1aQzJWTGpuSVNMdXV2cjk5QUZWeUp3eWc1Z3E2MG9GcWhpVUF4MGt2ekFWMHpxTDFHeDdYUGVVVmZjZ0h4N1BJQ3p6ZzdCRlJBYjduc29uX0tmLTlOTDhGQUJpVlZUMHpGVGVoemN4cHhwMnM</guid><pubDate>Thu, 08 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE1aQzJWTGpuSVNMdXV2cjk5QUZWeUp3eWc1Z3E2MG9GcWhpVUF4MGt2ekFWMHpxTDFHeDdYUGVVVmZjZ0h4N1BJQ3p6ZzdCRlJBYjduc29uX0tmLTlOTDhGQUJpVlZUMHpGVGVoemN4cHhwMnM?oc=5" target="_blank"&gt;'라투다' 성장세에 환인제약 이어 명인제약도 특허 도전장&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>[자사주 품앗이] [환인제약] 우호 지분 확보에도 2세 경영 불안 지속 - DealSite경제TV</title><link>https://news.google.com/rss/articles/CBMiVkFVX3lxTFBMNXhpYXBSUWdOalh3SWthemJYRmg0NFoyamRnZFppM3NVTkM2WGFWQWJzVndnNzFwOHFhTndQQ3lqWHJCUUlpYWV6VGFvTDlvQ0NTcWJB?oc=5</link><guid isPermaLink="false">CBMiVkFVX3lxTFBMNXhpYXBSUWdOalh3SWthemJYRmg0NFoyamRnZFppM3NVTkM2WGFWQWJzVndnNzFwOHFhTndQQ3lqWHJCUUlpYWV6VGFvTDlvQ0NTcWJB</guid><pubDate>Tue, 13 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTFBMNXhpYXBSUWdOalh3SWthemJYRmg0NFoyamRnZFppM3NVTkM2WGFWQWJzVndnNzFwOHFhTndQQ3lqWHJCUUlpYWV6VGFvTDlvQ0NTcWJB?oc=5" target="_blank"&gt;[자사주 품앗이] [환인제약] 우호 지분 확보에도 2세 경영 불안 지속&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;DealSite경제TV&lt;/font&gt;</description><source url="https://news.dealsitetv.com">DealSite경제TV</source></item><item><title>환인제약, 1Q 연결 영업이익 93억...전년비 77%↑ - 데이터투자</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE1lYy05TWQ2QXBfcEttU0NXeUc4TnJIeXpwUi1HOE9kM2Rhem1DMDZUNTU0V2JDUmRWQzdJRk5wbGtoeFF1bGtDMHlQZTNSWjFtdE5fTHFvaFRkd3I1cVFGaW5fZE1fRjhtblp2VzV3WE9PWkU?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE1lYy05TWQ2QXBfcEttU0NXeUc4TnJIeXpwUi1HOE9kM2Rhem1DMDZUNTU0V2JDUmRWQzdJRk5wbGtoeFF1bGtDMHlQZTNSWjFtdE5fTHFvaFRkd3I1cVFGaW5fZE1fRjhtblp2VzV3WE9PWkU</guid><pubDate>Mon, 27 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE1lYy05TWQ2QXBfcEttU0NXeUc4TnJIeXpwUi1HOE9kM2Rhem1DMDZUNTU0V2JDUmRWQzdJRk5wbGtoeFF1bGtDMHlQZTNSWjFtdE5fTHFvaFRkd3I1cVFGaW5fZE1fRjhtblp2VzV3WE9PWkU?oc=5" target="_blank"&gt;환인제약, 1Q 연결 영업이익 93억...전년비 77%↑&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데이터투자&lt;/font&gt;</description><source url="https://www.datatooza.com">데이터투자</source></item><item><title>환인제약, CNS 넘어 ‘마이크로바이옴ㆍ동물약’으로 확대 - 의약뉴스</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTFBQd0JnelhCUUtqUk5sYTA0ZFBBQ0NmNFZ3X2Y1NWlSY09LM1YzenV4bDRJWU9sQXRmUmx4LWpEU1p1aS10YlRLa0RTbzNPVTJRNWhRTjdhTEJqM3JDdXk2WmZzVnpsakNr?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTFBQd0JnelhCUUtqUk5sYTA0ZFBBQ0NmNFZ3X2Y1NWlSY09LM1YzenV4bDRJWU9sQXRmUmx4LWpEU1p1aS10YlRLa0RTbzNPVTJRNWhRTjdhTEJqM3JDdXk2WmZzVnpsakNr</guid><pubDate>Tue, 02 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTFBQd0JnelhCUUtqUk5sYTA0ZFBBQ0NmNFZ3X2Y1NWlSY09LM1YzenV4bDRJWU9sQXRmUmx4LWpEU1p1aS10YlRLa0RTbzNPVTJRNWhRTjdhTEJqM3JDdXk2WmZzVnpsakNr?oc=5" target="_blank"&gt;환인제약, CNS 넘어 ‘마이크로바이옴ㆍ동물약’으로 확대&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의약뉴스&lt;/font&gt;</description><source url="https://www.newsmp.com">의약뉴스</source></item><item><title>환인제약, 기업가치 제고 계획 공시…2026년 매출 목표 2800억 제시 - fetv.co.kr</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE4yWFM5MTFPRzZRZGQ2M0Uyb21BODRPUG5HaWRMT09fZjZEbGZvSV91bE1TaWtpOU9xS2cwWWNuX0tMQlhXV0RuTDJzRGg1ZGZSNk9HanhoSWlZcFh2RjgwdUtGbDg1YTdm?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE4yWFM5MTFPRzZRZGQ2M0Uyb21BODRPUG5HaWRMT09fZjZEbGZvSV91bE1TaWtpOU9xS2cwWWNuX0tMQlhXV0RuTDJzRGg1ZGZSNk9HanhoSWlZcFh2RjgwdUtGbDg1YTdm</guid><pubDate>Mon, 23 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE4yWFM5MTFPRzZRZGQ2M0Uyb21BODRPUG5HaWRMT09fZjZEbGZvSV91bE1TaWtpOU9xS2cwWWNuX0tMQlhXV0RuTDJzRGg1ZGZSNk9HanhoSWlZcFh2RjgwdUtGbDg1YTdm?oc=5" target="_blank"&gt;환인제약, 기업가치 제고 계획 공시…2026년 매출 목표 2800억 제시&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;fetv.co.kr&lt;/font&gt;</description><source url="https://www.fetv.co.kr">fetv.co.kr</source></item><item><title>환인제약, 대만 ANXO사와 ADHD 치료제 독점 개발 및 공급계약 체결 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE9uMXZQbVVSVWktRzdqVzBfVWt2eVhvbGVvZ0QxYUhaTWJ3UUsxTlhyRkxWLWdjWUN4dUJ5U0praTVFakhKUWJLUFZDSWlXVlhac2E3WDM5U2ZuaGJTWDBTaFBzd1hLMm5jdm16Nw?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE9uMXZQbVVSVWktRzdqVzBfVWt2eVhvbGVvZ0QxYUhaTWJ3UUsxTlhyRkxWLWdjWUN4dUJ5U0praTVFakhKUWJLUFZDSWlXVlhac2E3WDM5U2ZuaGJTWDBTaFBzd1hLMm5jdm16Nw</guid><pubDate>Thu, 30 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9uMXZQbVVSVWktRzdqVzBfVWt2eVhvbGVvZ0QxYUhaTWJ3UUsxTlhyRkxWLWdjWUN4dUJ5U0praTVFakhKUWJLUFZDSWlXVlhac2E3WDM5U2ZuaGJTWDBTaFBzd1hLMm5jdm16Nw?oc=5" target="_blank"&gt;환인제약, 대만 ANXO사와 ADHD 치료제 독점 개발 및 공급계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>환인제약 투자분석 2026. 03. 05 - 주달</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTFA4ajhuTUREb2Y2M1lEWEt4bXNqNjZ4ZVpWYVRwNHJ5Q2lWUXJIRWs3bmNjVDhMOW8tUGk0T1diNS1ZdVN6YnF1QnNRMnMxbE1mQ1ZDSkVjb1p5Y2d2RFdIcTBZanlXdWotY0k3cVczOWRYdkE?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTFA4ajhuTUREb2Y2M1lEWEt4bXNqNjZ4ZVpWYVRwNHJ5Q2lWUXJIRWs3bmNjVDhMOW8tUGk0T1diNS1ZdVN6YnF1QnNRMnMxbE1mQ1ZDSkVjb1p5Y2d2RFdIcTBZanlXdWotY0k3cVczOWRYdkE</guid><pubDate>Thu, 05 Mar 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTFA4ajhuTUREb2Y2M1lEWEt4bXNqNjZ4ZVpWYVRwNHJ5Q2lWUXJIRWs3bmNjVDhMOW8tUGk0T1diNS1ZdVN6YnF1QnNRMnMxbE1mQ1ZDSkVjb1p5Y2d2RFdIcTBZanlXdWotY0k3cVczOWRYdkE?oc=5" target="_blank"&gt;환인제약 투자분석 2026. 03. 05&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;주달&lt;/font&gt;</description><source url="https://www.judal.co.kr">주달</source></item><item><title>환인제약, 뇌전증 치료제 브리바정 발매 外 - 의약뉴스</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE8xN1lrOVVqZnZfYm1JRjNRWWFXclMyTkkwdDFMOV8xMDVBLVBJQ1hleVdod2k0QmpucE9HcHNKbDFNeG1FRk9vYnVxOUNpX2dmN19YQzlINllWakd6SExqa0M3R0tXTzg4?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE8xN1lrOVVqZnZfYm1JRjNRWWFXclMyTkkwdDFMOV8xMDVBLVBJQ1hleVdod2k0QmpucE9HcHNKbDFNeG1FRk9vYnVxOUNpX2dmN19YQzlINllWakd6SExqa0M3R0tXTzg4</guid><pubDate>Mon, 23 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE8xN1lrOVVqZnZfYm1JRjNRWWFXclMyTkkwdDFMOV8xMDVBLVBJQ1hleVdod2k0QmpucE9HcHNKbDFNeG1FRk9vYnVxOUNpX2dmN19YQzlINllWakd6SExqa0M3R0tXTzg4?oc=5" target="_blank"&gt;환인제약, 뇌전증 치료제 브리바정 발매 外&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의약뉴스&lt;/font&gt;</description><source url="https://www.newsmp.com">의약뉴스</source></item><item><title>환인제약 투자분석 2026. 02. 16 - 주달</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE5Ia2FiU3RsRFNUWHV2N202WVlNS3pvWEtTVmtVa0tENjZRSm1zNi1pNGJvMWN0OGVZSlpOb2hJNzB1Ym5KZXNNcG92Y0IxOEpVNk44N1M4ODRmVzA3VE4zRm9fZ0N4Wi16ZThEbUctalFWWE0?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE5Ia2FiU3RsRFNUWHV2N202WVlNS3pvWEtTVmtVa0tENjZRSm1zNi1pNGJvMWN0OGVZSlpOb2hJNzB1Ym5KZXNNcG92Y0IxOEpVNk44N1M4ODRmVzA3VE4zRm9fZ0N4Wi16ZThEbUctalFWWE0</guid><pubDate>Mon, 16 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE5Ia2FiU3RsRFNUWHV2N202WVlNS3pvWEtTVmtVa0tENjZRSm1zNi1pNGJvMWN0OGVZSlpOb2hJNzB1Ym5KZXNNcG92Y0IxOEpVNk44N1M4ODRmVzA3VE4zRm9fZ0N4Wi16ZThEbUctalFWWE0?oc=5" target="_blank"&gt;환인제약 투자분석 2026. 02. 16&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;주달&lt;/font&gt;</description><source url="https://www.judal.co.kr">주달</source></item><item><title>환인제약, 정신의학 연구자 발굴 28년…“학술 경쟁력 강화 기여” - 헬스포커스뉴스</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE15ZXBJM1Q1UHlGLWQzOEdfbUxyM2pEbERWZURxSUJHZzhIWTh6N0tJV1NGZzd0WGR1Wl92VldGSkU3aVQ4SXM1cVpCalBSbV9xa0JSUUYtcTl5TXVyWDdRR0xlTUJEMklpaS01TmUxNXc3Zw?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE15ZXBJM1Q1UHlGLWQzOEdfbUxyM2pEbERWZURxSUJHZzhIWTh6N0tJV1NGZzd0WGR1Wl92VldGSkU3aVQ4SXM1cVpCalBSbV9xa0JSUUYtcTl5TXVyWDdRR0xlTUJEMklpaS01TmUxNXc3Zw</guid><pubDate>Mon, 20 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE15ZXBJM1Q1UHlGLWQzOEdfbUxyM2pEbERWZURxSUJHZzhIWTh6N0tJV1NGZzd0WGR1Wl92VldGSkU3aVQ4SXM1cVpCalBSbV9xa0JSUUYtcTl5TXVyWDdRR0xlTUJEMklpaS01TmUxNXc3Zw?oc=5" target="_blank"&gt;환인제약, 정신의학 연구자 발굴 28년…“학술 경쟁력 강화 기여”&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;헬스포커스뉴스&lt;/font&gt;</description><source url="https://www.healthfocus.co.kr">헬스포커스뉴스</source></item><item><title>﻿환인제약, 동국·진양·경동제약 ‘자사주 혈맹’ - 데일리메디</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE4tVFlIZkhtZVNLd0dLOTRWNHplNEQ5R3FSZnh5bXpmTTlDVHZDbjdmeEQ3SEF2M1NKcnBkeHZ6WHZGUnhlU3NZZVVaN0hzcGpqNV9sTlVpNFE1OEdWRWVhMGkwTVlkb09P?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE4tVFlIZkhtZVNLd0dLOTRWNHplNEQ5R3FSZnh5bXpmTTlDVHZDbjdmeEQ3SEF2M1NKcnBkeHZ6WHZGUnhlU3NZZVVaN0hzcGpqNV9sTlVpNFE1OEdWRWVhMGkwTVlkb09P</guid><pubDate>Sun, 14 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE4tVFlIZkhtZVNLd0dLOTRWNHplNEQ5R3FSZnh5bXpmTTlDVHZDbjdmeEQ3SEF2M1NKcnBkeHZ6WHZGUnhlU3NZZVVaN0hzcGpqNV9sTlVpNFE1OEdWRWVhMGkwTVlkb09P?oc=5" target="_blank"&gt;﻿환인제약, 동국·진양·경동제약 ‘자사주 혈맹’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리메디&lt;/font&gt;</description><source url="https://www.dailymedi.com">데일리메디</source></item><item><title>환인제약 투자분석 2026. 05. 01 - 주달</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE1fVFFadDFIU0gxNldOSS1FRkRRZTBxem5VdmNhUGVmbUczdWY1MXRyZmM3SjBReHRmMVJpNmZ2aU5kejBOejZxLURTX1dLNFJocldiNTRUa2tieVVPRXllOXY4ejFHWnFnVEo3RWNtWC1HVjg?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE1fVFFadDFIU0gxNldOSS1FRkRRZTBxem5VdmNhUGVmbUczdWY1MXRyZmM3SjBReHRmMVJpNmZ2aU5kejBOejZxLURTX1dLNFJocldiNTRUa2tieVVPRXllOXY4ejFHWnFnVEo3RWNtWC1HVjg</guid><pubDate>Fri, 01 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE1fVFFadDFIU0gxNldOSS1FRkRRZTBxem5VdmNhUGVmbUczdWY1MXRyZmM3SjBReHRmMVJpNmZ2aU5kejBOejZxLURTX1dLNFJocldiNTRUa2tieVVPRXllOXY4ejFHWnFnVEo3RWNtWC1HVjg?oc=5" target="_blank"&gt;환인제약 투자분석 2026. 05. 01&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;주달&lt;/font&gt;</description><source url="https://www.judal.co.kr">주달</source></item><item><title>환인제약, 파킨슨병·조현병 신약 연구개발 전면 중단…개량신약·제네릭으로 대체 - 메디컬투데이</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTE94UVk3WUpUYkRzS2VaQkZjejItcFdDYTRsZURiY2dHWU43Vk9nWnNyTWRrWE9VZ0VjRVE2U19BZHF4dWZ1ekpQc1dkMGJHM3FfUEtMV29ZdEloV0xS0gFsQVVfeXFMTklwLTNTbDA1MExxOTlsc2ZOVTNxa0VqMTNxTGs3UVR0SThoN2NPOVpnN1U5Zi1fZVpFQU9WSG5PTFZzUUU0Ry14VF9yaE94RzU3OGxDTGNCR3dRUm8zVkZKZmRGRzdpMmdTQzRS?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTE94UVk3WUpUYkRzS2VaQkZjejItcFdDYTRsZURiY2dHWU43Vk9nWnNyTWRrWE9VZ0VjRVE2U19BZHF4dWZ1ekpQc1dkMGJHM3FfUEtMV29ZdEloV0xS0gFsQVVfeXFMTklwLTNTbDA1MExxOTlsc2ZOVTNxa0VqMTNxTGs3UVR0SThoN2NPOVpnN1U5Zi1fZVpFQU9WSG5PTFZzUUU0Ry14VF9yaE94RzU3OGxDTGNCR3dRUm8zVkZKZmRGRzdpMmdTQzRS</guid><pubDate>Mon, 20 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE94UVk3WUpUYkRzS2VaQkZjejItcFdDYTRsZURiY2dHWU43Vk9nWnNyTWRrWE9VZ0VjRVE2U19BZHF4dWZ1ekpQc1dkMGJHM3FfUEtMV29ZdEloV0xS0gFsQVVfeXFMTklwLTNTbDA1MExxOTlsc2ZOVTNxa0VqMTNxTGs3UVR0SThoN2NPOVpnN1U5Zi1fZVpFQU9WSG5PTFZzUUU0Ry14VF9yaE94RzU3OGxDTGNCR3dRUm8zVkZKZmRGRzdpMmdTQzRS?oc=5" target="_blank"&gt;환인제약, 파킨슨병·조현병 신약 연구개발 전면 중단…개량신약·제네릭으로 대체&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디컬투데이&lt;/font&gt;</description><source url="https://mdtoday.co.kr">메디컬투데이</source></item><item><title>[거버넌스워치] 환인제약 13년에 걸친 이광식-원범 父子 경영 체제 - v.daum.net</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE9UMHBpcHFLMm11cUdNU1dUamMtdDhleDJFNmJ5RTVLSUFxQ1psZ1Juem1NRzNZZTU0Wlh3czA2c3RVRHo5Rmx6LVdpdncyazQ?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE9UMHBpcHFLMm11cUdNU1dUamMtdDhleDJFNmJ5RTVLSUFxQ1psZ1Juem1NRzNZZTU0Wlh3czA2c3RVRHo5Rmx6LVdpdncyazQ</guid><pubDate>Tue, 21 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE9UMHBpcHFLMm11cUdNU1dUamMtdDhleDJFNmJ5RTVLSUFxQ1psZ1Juem1NRzNZZTU0Wlh3czA2c3RVRHo5Rmx6LVdpdncyazQ?oc=5" target="_blank"&gt;[거버넌스워치] 환인제약 13년에 걸친 이광식-원범 父子 경영 체제&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;v.daum.net&lt;/font&gt;</description><source url="https://v.daum.net">v.daum.net</source></item><item><title>[제약 Weekly]환인, 동국·진양·경동과 주식 맞교환 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFBaTV9HSXlGZ2JuMFdPQ0tkbUp2WmRBUFlKcUdpeHN2cWs2QkU0VmNXekFZRlplbUFXMVkzNVRtRXNOWE1GUHdOZnJNbVpZMHZrSVduUEhfbVdXeFM4a1JJcTRFckRudHdmTmc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFBaTV9HSXlGZ2JuMFdPQ0tkbUp2WmRBUFlKcUdpeHN2cWs2QkU0VmNXekFZRlplbUFXMVkzNVRtRXNOWE1GUHdOZnJNbVpZMHZrSVduUEhfbVdXeFM4a1JJcTRFckRudHdmTmc</guid><pubDate>Fri, 12 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBaTV9HSXlGZ2JuMFdPQ0tkbUp2WmRBUFlKcUdpeHN2cWs2QkU0VmNXekFZRlplbUFXMVkzNVRtRXNOWE1GUHdOZnJNbVpZMHZrSVduUEhfbVdXeFM4a1JJcTRFckRudHdmTmc?oc=5" target="_blank"&gt;[제약 Weekly]환인, 동국·진양·경동과 주식 맞교환&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>“美서 9억 달러 짜리인데” … 환인제약, 조현병 신약 도입 포기 - 메디소비자뉴스</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE0zbjh4a3YyNXZ1eVNUYzh0UVV4YkExUWU5UUloaVZubm85S2VFd2JvUThFdGlPUzdFSkdaNWsxZmluTTRDaFdMZ3VLTlJnbVc2UVFMSXliX1lHOHlSLTU4bDVnSFB1MG14eGNHNnBobDlyQdIBdkFVX3lxTFBDdXhqRklEZG4ya2diSU9EaWtMV01PZE1ZT2xmbkUyVU54SFlPTkhlWXRoYWdNVXRJS0VaRHUwMVEzUmF6M2ZVbnVlZWd2Nldwbi1oM1M3TnVnbG5ITV92cFNGbDFFODRfaW1mQkk2ZVR4NlF0ZFE?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE0zbjh4a3YyNXZ1eVNUYzh0UVV4YkExUWU5UUloaVZubm85S2VFd2JvUThFdGlPUzdFSkdaNWsxZmluTTRDaFdMZ3VLTlJnbVc2UVFMSXliX1lHOHlSLTU4bDVnSFB1MG14eGNHNnBobDlyQdIBdkFVX3lxTFBDdXhqRklEZG4ya2diSU9EaWtMV01PZE1ZT2xmbkUyVU54SFlPTkhlWXRoYWdNVXRJS0VaRHUwMVEzUmF6M2ZVbnVlZWd2Nldwbi1oM1M3TnVnbG5ITV92cFNGbDFFODRfaW1mQkk2ZVR4NlF0ZFE</guid><pubDate>Fri, 14 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE0zbjh4a3YyNXZ1eVNUYzh0UVV4YkExUWU5UUloaVZubm85S2VFd2JvUThFdGlPUzdFSkdaNWsxZmluTTRDaFdMZ3VLTlJnbVc2UVFMSXliX1lHOHlSLTU4bDVnSFB1MG14eGNHNnBobDlyQdIBdkFVX3lxTFBDdXhqRklEZG4ya2diSU9EaWtMV01PZE1ZT2xmbkUyVU54SFlPTkhlWXRoYWdNVXRJS0VaRHUwMVEzUmF6M2ZVbnVlZWd2Nldwbi1oM1M3TnVnbG5ITV92cFNGbDFFODRfaW1mQkk2ZVR4NlF0ZFE?oc=5" target="_blank"&gt;“美서 9억 달러 짜리인데” … 환인제약, 조현병 신약 도입 포기&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디소비자뉴스&lt;/font&gt;</description><source url="http://www.medisobizanews.com">메디소비자뉴스</source></item><item><title>환인제약, 궤양성 대장염 치료제 10mg 추가 출시 - 한국의약통신</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFAwalZGS280OVF0aktVdXpmMXY3a1I4Wms5VWNKN0NnZE03ZFdiQVktUWRwTTM3QVpSSEtrYi1CaXM3XzQ5RXJ1OXVGeExHclh2WDNpTUJWeDFHQlJGdDA5aU1oYm8xV1J0WlA4?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFAwalZGS280OVF0aktVdXpmMXY3a1I4Wms5VWNKN0NnZE03ZFdiQVktUWRwTTM3QVpSSEtrYi1CaXM3XzQ5RXJ1OXVGeExHclh2WDNpTUJWeDFHQlJGdDA5aU1oYm8xV1J0WlA4</guid><pubDate>Mon, 02 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFAwalZGS280OVF0aktVdXpmMXY3a1I4Wms5VWNKN0NnZE03ZFdiQVktUWRwTTM3QVpSSEtrYi1CaXM3XzQ5RXJ1OXVGeExHclh2WDNpTUJWeDFHQlJGdDA5aU1oYm8xV1J0WlA4?oc=5" target="_blank"&gt;환인제약, 궤양성 대장염 치료제 10mg 추가 출시&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국의약통신&lt;/font&gt;</description><source url="https://www.kmpnews.co.kr">한국의약통신</source></item><item><title>[리포트 브리핑]환인제약, '기대치 이상의 실적' 목표가 17,000원 - LS증권 - 뉴스핌</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTE1sTjVlM1JLRElPaGNNWmRQdFNWOWFCdzJCem5kQUZFSGpveDNUX255QkFCX1VkMGtHZkdyQy1iN2l1dWRTTmZENHIyRzQzXzNpNWtCOGNYS00wRGhk?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTE1sTjVlM1JLRElPaGNNWmRQdFNWOWFCdzJCem5kQUZFSGpveDNUX255QkFCX1VkMGtHZkdyQy1iN2l1dWRTTmZENHIyRzQzXzNpNWtCOGNYS00wRGhk</guid><pubDate>Wed, 29 Apr 2026 06:21:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE1sTjVlM1JLRElPaGNNWmRQdFNWOWFCdzJCem5kQUZFSGpveDNUX255QkFCX1VkMGtHZkdyQy1iN2l1dWRTTmZENHIyRzQzXzNpNWtCOGNYS00wRGhk?oc=5" target="_blank"&gt;[리포트 브리핑]환인제약, '기대치 이상의 실적' 목표가 17,000원 - LS증권&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스핌&lt;/font&gt;</description><source url="https://www.newspim.com">뉴스핌</source></item><item><title>출시 1년만에 시작된 '라투다' 특허도전, 환인 첫 테이프 끊어 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE82Zzk2MF9nUVZ5cktKYUtuQjZONy1LN3M5aHg1MC14UkstcWcxQmhYaVNsUFhhUnQ5YjZ6a1FaZ0VoWXdCSzJuMnpRQmZ6VV9HLXZsNWdGQjZiX0J3Rm9aSnMtR0NqY2VkNzlJ?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE82Zzk2MF9nUVZ5cktKYUtuQjZONy1LN3M5aHg1MC14UkstcWcxQmhYaVNsUFhhUnQ5YjZ6a1FaZ0VoWXdCSzJuMnpRQmZ6VV9HLXZsNWdGQjZiX0J3Rm9aSnMtR0NqY2VkNzlJ</guid><pubDate>Sat, 27 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE82Zzk2MF9nUVZ5cktKYUtuQjZONy1LN3M5aHg1MC14UkstcWcxQmhYaVNsUFhhUnQ5YjZ6a1FaZ0VoWXdCSzJuMnpRQmZ6VV9HLXZsNWdGQjZiX0J3Rm9aSnMtR0NqY2VkNzlJ?oc=5" target="_blank"&gt;출시 1년만에 시작된 '라투다' 특허도전, 환인 첫 테이프 끊어&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>환인제약, 동국제약·진양제약·경동제약과 자사주 맞교환…상법개정안 대응·‘지분 연대’ 구축 - PRESS9</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTFBJTWVnQlROZkV4WkM4b1hyUnhKd0R4c28tcE81UGtfd3h4dWVKdjR2MkxpSjgzV3BTQ3R5UXlqbUt0WVhMVlkzSjcyNV9wOHBIc3dQWDdiRGJDYzJ0RlFpb3NkYmJudw?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTFBJTWVnQlROZkV4WkM4b1hyUnhKd0R4c28tcE81UGtfd3h4dWVKdjR2MkxpSjgzV3BTQ3R5UXlqbUt0WVhMVlkzSjcyNV9wOHBIc3dQWDdiRGJDYzJ0RlFpb3NkYmJudw</guid><pubDate>Wed, 17 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTFBJTWVnQlROZkV4WkM4b1hyUnhKd0R4c28tcE81UGtfd3h4dWVKdjR2MkxpSjgzV3BTQ3R5UXlqbUt0WVhMVlkzSjcyNV9wOHBIc3dQWDdiRGJDYzJ0RlFpb3NkYmJudw?oc=5" target="_blank"&gt;환인제약, 동국제약·진양제약·경동제약과 자사주 맞교환…상법개정안 대응·‘지분 연대’ 구축&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PRESS9&lt;/font&gt;</description><source url="https://www.press9.kr">PRESS9</source></item><item><title>환인제약 투자분석 2026. 04. 21 - 주달</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE9TYnZDQjhUX19EczVfWk1KRnE1ZU1iRXQ1WmIzSzkyU0NxakROejgwcU1kX3N3Qkt1dFUzOENSWXU1Rkw5MnpfT2Z3U2M5Wk9pS2s3Ykd6bDc1S2FmWGN4QkpqNHFPSkw5SEl4d3JFTmxmRG8?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE9TYnZDQjhUX19EczVfWk1KRnE1ZU1iRXQ1WmIzSzkyU0NxakROejgwcU1kX3N3Qkt1dFUzOENSWXU1Rkw5MnpfT2Z3U2M5Wk9pS2s3Ykd6bDc1S2FmWGN4QkpqNHFPSkw5SEl4d3JFTmxmRG8</guid><pubDate>Tue, 21 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9TYnZDQjhUX19EczVfWk1KRnE1ZU1iRXQ1WmIzSzkyU0NxakROejgwcU1kX3N3Qkt1dFUzOENSWXU1Rkw5MnpfT2Z3U2M5Wk9pS2s3Ykd6bDc1S2FmWGN4QkpqNHFPSkw5SEl4d3JFTmxmRG8?oc=5" target="_blank"&gt;환인제약 투자분석 2026. 04. 21&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;주달&lt;/font&gt;</description><source url="https://www.judal.co.kr">주달</source></item><item><title>ADHD 치료제 '콘서타' 독주 흔들리나…환인제약, 'OROS 서방정' 제네릭 도전 - 메디팜스투데이</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE1YR2V1bTVTc0RFMElJT1RGLWpCQWxfMVl6aHpOZkZnbmE0d0o3b1RQRENrNm5YNHVzN09YT2ZaUmItWE9OYVVoRFZxd1pfS3lEN2RlakxrYUZSYnNneDJJWThuY0twVzY0?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE1YR2V1bTVTc0RFMElJT1RGLWpCQWxfMVl6aHpOZkZnbmE0d0o3b1RQRENrNm5YNHVzN09YT2ZaUmItWE9OYVVoRFZxd1pfS3lEN2RlakxrYUZSYnNneDJJWThuY0twVzY0</guid><pubDate>Tue, 10 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE1YR2V1bTVTc0RFMElJT1RGLWpCQWxfMVl6aHpOZkZnbmE0d0o3b1RQRENrNm5YNHVzN09YT2ZaUmItWE9OYVVoRFZxd1pfS3lEN2RlakxrYUZSYnNneDJJWThuY0twVzY0?oc=5" target="_blank"&gt;ADHD 치료제 '콘서타' 독주 흔들리나…환인제약, 'OROS 서방정' 제네릭 도전&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디팜스투데이&lt;/font&gt;</description><source url="https://www.apsk.co.kr">메디팜스투데이</source></item><item><title>환인제약 외국계 펀드와 경영권 분쟁의 산물 자사주 13%, 이광식 상법 개정 추진에 딜레마 - 비즈니스포스트</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE1UeVRmS0ttRjBzYWhXMXJtMi1tY3JaVVAwVXBEYXJZaWx5amRuVnFYZm1MNDNOXzR5bU1jT3FMX21xUFkwZzduTzFuZXZXcWtaR0NIZ0t6ajJCekFMVFMxNUpCNmN6WkJxWWNRWjlFamVtQ28?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE1UeVRmS0ttRjBzYWhXMXJtMi1tY3JaVVAwVXBEYXJZaWx5amRuVnFYZm1MNDNOXzR5bU1jT3FMX21xUFkwZzduTzFuZXZXcWtaR0NIZ0t6ajJCekFMVFMxNUpCNmN6WkJxWWNRWjlFamVtQ28</guid><pubDate>Mon, 20 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE1UeVRmS0ttRjBzYWhXMXJtMi1tY3JaVVAwVXBEYXJZaWx5amRuVnFYZm1MNDNOXzR5bU1jT3FMX21xUFkwZzduTzFuZXZXcWtaR0NIZ0t6ajJCekFMVFMxNUpCNmN6WkJxWWNRWjlFamVtQ28?oc=5" target="_blank"&gt;환인제약 외국계 펀드와 경영권 분쟁의 산물 자사주 13%, 이광식 상법 개정 추진에 딜레마&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;비즈니스포스트&lt;/font&gt;</description><source url="https://www.businesspost.co.kr">비즈니스포스트</source></item><item><title>환인제약, 뇌전증 치료제 ‘브리바®정’ 5개 전 용량 국내 유일 동시 발매 - 약업신문</title><link>https://news.google.com/rss/articles/CBMid0FVX3lxTE5WcmExa2trOEhEckcxUFo3aXIyVjhDbUFFZ3FPVFFYOHBTNHBVTGgxMm92YVFCWkJHaE1EWGlTOG4wVGRydG5qUGphMUFZOUpqbDVMRlF0a0FFYkZTbVdmNkYzbzcwTTZiR0dKa2RIaHFfb3JMZmRv?oc=5</link><guid isPermaLink="false">CBMid0FVX3lxTE5WcmExa2trOEhEckcxUFo3aXIyVjhDbUFFZ3FPVFFYOHBTNHBVTGgxMm92YVFCWkJHaE1EWGlTOG4wVGRydG5qUGphMUFZOUpqbDVMRlF0a0FFYkZTbVdmNkYzbzcwTTZiR0dKa2RIaHFfb3JMZmRv</guid><pubDate>Mon, 23 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE5WcmExa2trOEhEckcxUFo3aXIyVjhDbUFFZ3FPVFFYOHBTNHBVTGgxMm92YVFCWkJHaE1EWGlTOG4wVGRydG5qUGphMUFZOUpqbDVMRlF0a0FFYkZTbVdmNkYzbzcwTTZiR0dKa2RIaHFfb3JMZmRv?oc=5" target="_blank"&gt;환인제약, 뇌전증 치료제 ‘브리바®정’ 5개 전 용량 국내 유일 동시 발매&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>환인제약, 뇌전증 치료제 '브리바정' 5개 함량 출시 - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1YS3FtZGtGbkJLNGp0TUE0MjRGOS1vN2MtOGM5dzlTc2xQYlZuOEthdzljYk9wVXg0eE02aDNYLXJhLUpHSWFSenA3NFNFOWxKemxXYjdqMjV6clpjN2g1Y1V0NTBZNGNsc0FJ?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1YS3FtZGtGbkJLNGp0TUE0MjRGOS1vN2MtOGM5dzlTc2xQYlZuOEthdzljYk9wVXg0eE02aDNYLXJhLUpHSWFSenA3NFNFOWxKemxXYjdqMjV6clpjN2g1Y1V0NTBZNGNsc0FJ</guid><pubDate>Mon, 23 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1YS3FtZGtGbkJLNGp0TUE0MjRGOS1vN2MtOGM5dzlTc2xQYlZuOEthdzljYk9wVXg0eE02aDNYLXJhLUpHSWFSenA3NFNFOWxKemxXYjdqMjV6clpjN2g1Y1V0NTBZNGNsc0FJ?oc=5" target="_blank"&gt;환인제약, 뇌전증 치료제 '브리바정' 5개 함량 출시&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>환인제약 만난 비피도, 경영정상화 넘어 실적 경신 도전 - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFByQ3o1ZFhYZ1k0Z1RiY0tyaEJQcEY0em1xNHFDb1JKcFlGMU91N0gxVFhjUElIWElPQjYxLUloNmh0TVlvR1JncmI5d3dERzNvUXdweFlrd3A3ZmlGVUlVWmtVZnl0RS1NN3ln?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFByQ3o1ZFhYZ1k0Z1RiY0tyaEJQcEY0em1xNHFDb1JKcFlGMU91N0gxVFhjUElIWElPQjYxLUloNmh0TVlvR1JncmI5d3dERzNvUXdweFlrd3A3ZmlGVUlVWmtVZnl0RS1NN3ln</guid><pubDate>Mon, 01 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFByQ3o1ZFhYZ1k0Z1RiY0tyaEJQcEY0em1xNHFDb1JKcFlGMU91N0gxVFhjUElIWElPQjYxLUloNmh0TVlvR1JncmI5d3dERzNvUXdweFlrd3A3ZmlGVUlVWmtVZnl0RS1NN3ln?oc=5" target="_blank"&gt;환인제약 만난 비피도, 경영정상화 넘어 실적 경신 도전&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>환인제약 투자분석 2026. 04. 11 - 주달</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTFBraHZlNGVja3ptaTJ3TUNOazVORklXWEduN0ViTlFPcVdFbTBzc1RpY2tQN3BpX2tEeE12c3FoUzd6cXJtZ3lnamhuaVFWUnFraU5ibXR0UGJld1FUbUstMkNoZ1ZrTHBWc0VuZ2QyY3ZObXM?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTFBraHZlNGVja3ptaTJ3TUNOazVORklXWEduN0ViTlFPcVdFbTBzc1RpY2tQN3BpX2tEeE12c3FoUzd6cXJtZ3lnamhuaVFWUnFraU5ibXR0UGJld1FUbUstMkNoZ1ZrTHBWc0VuZ2QyY3ZObXM</guid><pubDate>Sat, 11 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTFBraHZlNGVja3ptaTJ3TUNOazVORklXWEduN0ViTlFPcVdFbTBzc1RpY2tQN3BpX2tEeE12c3FoUzd6cXJtZ3lnamhuaVFWUnFraU5ibXR0UGJld1FUbUstMkNoZ1ZrTHBWc0VuZ2QyY3ZObXM?oc=5" target="_blank"&gt;환인제약 투자분석 2026. 04. 11&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;주달&lt;/font&gt;</description><source url="https://www.judal.co.kr">주달</source></item><item><title>동국·진양 이어 한국유나이티드제약 ‘자사주 스왑’ - 데일리메디</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE41TWNCMEUyV1hpbllrZFBaRXpjWDJEdU03eUJBV1JkblhTRmlZdHo0Uk9USTc4dDQ2dUlnVERza1cwOTYyUVJ2TXJORnYzNGZrUGloSV9lblZfbkxYRDlwXzA1ODQ0TFR6?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE41TWNCMEUyV1hpbllrZFBaRXpjWDJEdU03eUJBV1JkblhTRmlZdHo0Uk9USTc4dDQ2dUlnVERza1cwOTYyUVJ2TXJORnYzNGZrUGloSV9lblZfbkxYRDlwXzA1ODQ0TFR6</guid><pubDate>Tue, 23 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE41TWNCMEUyV1hpbllrZFBaRXpjWDJEdU03eUJBV1JkblhTRmlZdHo0Uk9USTc4dDQ2dUlnVERza1cwOTYyUVJ2TXJORnYzNGZrUGloSV9lblZfbkxYRDlwXzA1ODQ0TFR6?oc=5" target="_blank"&gt;동국·진양 이어 한국유나이티드제약 ‘자사주 스왑’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리메디&lt;/font&gt;</description><source url="https://www.dailymedi.com">데일리메디</source></item><item><title>환인제약 애즈유·라우드코퍼레이션, K-컬처 융합 '맞손' - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTE1CU2Joc2ljY1VSeVJ1VFRvQnp6Y0p0VHN0VkEtZ2pqSjdYV09hbElBNjlBQy1BSnJxcXg0TXBpRWRMQ3Nfd3pLUjV1ckt6YTFvYmF2MnBlQXRUaGgx?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTE1CU2Joc2ljY1VSeVJ1VFRvQnp6Y0p0VHN0VkEtZ2pqSjdYV09hbElBNjlBQy1BSnJxcXg0TXBpRWRMQ3Nfd3pLUjV1ckt6YTFvYmF2MnBlQXRUaGgx</guid><pubDate>Fri, 24 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE1CU2Joc2ljY1VSeVJ1VFRvQnp6Y0p0VHN0VkEtZ2pqSjdYV09hbElBNjlBQy1BSnJxcXg0TXBpRWRMQ3Nfd3pLUjV1ckt6YTFvYmF2MnBlQXRUaGgx?oc=5" target="_blank"&gt;환인제약 애즈유·라우드코퍼레이션, K-컬처 융합 '맞손'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://m.dailypharm.com">데일리팜</source></item><item><title>자사주 소각 의무화 앞둔 오너 2세들 선택은 '스왑딜' - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1Jc096dkx1SjcxMERmSmdmelQ3dW92MUt2ci0yZnhVbzZPUEMtT0hNSGJmTXBSSDZ0Smltc1BrNXYwQWVmVGRjUGhsb29vcjBoYmlCNGxiak9wYW14U2JwcEVQUEYxZ1Ywa3hJ?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1Jc096dkx1SjcxMERmSmdmelQ3dW92MUt2ci0yZnhVbzZPUEMtT0hNSGJmTXBSSDZ0Smltc1BrNXYwQWVmVGRjUGhsb29vcjBoYmlCNGxiak9wYW14U2JwcEVQUEYxZ1Ywa3hJ</guid><pubDate>Sat, 13 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1Jc096dkx1SjcxMERmSmdmelQ3dW92MUt2ci0yZnhVbzZPUEMtT0hNSGJmTXBSSDZ0Smltc1BrNXYwQWVmVGRjUGhsb29vcjBoYmlCNGxiak9wYW14U2JwcEVQUEYxZ1Ywa3hJ?oc=5" target="_blank"&gt;자사주 소각 의무화 앞둔 오너 2세들 선택은 '스왑딜'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>[Generic Trend]환인제약, '콘서타OROS서방정' 제네릭 개발 돌입 - PRESS9</title><link>https://news.google.com/rss/articles/CBMiZEFVX3lxTE43QkxZQm5WSzVzMmFIWXNXZHVkNFp1TWZPUFA1bGJCR1pzVlcyMUw2VlpDeHFnSlRRT0VSTWlreWpldkJ1c0JsbDNQRzBuR254SHV1ODh3VG1qOWpwR3Fhc2Y4bFY?oc=5</link><guid isPermaLink="false">CBMiZEFVX3lxTE43QkxZQm5WSzVzMmFIWXNXZHVkNFp1TWZPUFA1bGJCR1pzVlcyMUw2VlpDeHFnSlRRT0VSTWlreWpldkJ1c0JsbDNQRzBuR254SHV1ODh3VG1qOWpwR3Fhc2Y4bFY</guid><pubDate>Thu, 05 Mar 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE43QkxZQm5WSzVzMmFIWXNXZHVkNFp1TWZPUFA1bGJCR1pzVlcyMUw2VlpDeHFnSlRRT0VSTWlreWpldkJ1c0JsbDNQRzBuR254SHV1ODh3VG1qOWpwR3Fhc2Y4bFY?oc=5" target="_blank"&gt;[Generic Trend]환인제약, '콘서타OROS서방정' 제네릭 개발 돌입&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PRESS9&lt;/font&gt;</description><source url="http://www.press9.kr">PRESS9</source></item><item><title>환인제약, 신공장 가동률 상승·약가인하 기저효과로 이익 회복 전망 - 메디코파마</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE9NV090TFEwTXlfYW9VLTZUVGdpNlZVVVFHNG5pRk4wNDNScnhiNHROOXo4cFB4MFdqUC13SGV1OXNGcHhfdnFPWnd5VE5laGE4ME5tMVNITWlPYkxNNWQtMzVMd0tIZzJmMnQ0YWhXNmsxdw?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE9NV090TFEwTXlfYW9VLTZUVGdpNlZVVVFHNG5pRk4wNDNScnhiNHROOXo4cFB4MFdqUC13SGV1OXNGcHhfdnFPWnd5VE5laGE4ME5tMVNITWlPYkxNNWQtMzVMd0tIZzJmMnQ0YWhXNmsxdw</guid><pubDate>Tue, 09 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE9NV090TFEwTXlfYW9VLTZUVGdpNlZVVVFHNG5pRk4wNDNScnhiNHROOXo4cFB4MFdqUC13SGV1OXNGcHhfdnFPWnd5VE5laGE4ME5tMVNITWlPYkxNNWQtMzVMd0tIZzJmMnQ0YWhXNmsxdw?oc=5" target="_blank"&gt;환인제약, 신공장 가동률 상승·약가인하 기저효과로 이익 회복 전망&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디코파마&lt;/font&gt;</description><source url="https://www.medicopharma.co.kr">메디코파마</source></item><item><title>환인제약, 3Q 매출 1901억 원…상품 매출 성장에도 영업이익 44% ↓ - 약업신문</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE5WR0VkYzRib0dyR21wUXU0Tzg4XzJSOTVKOXE2LWloMjdFTnJRaml5NGdyeHFGYXNoYU9MYzJndld4RjY5d0lHWDZaSWZiTHcxSW9BdXBia3ZhTGY2T29GdWh5dEowUlR5ajdIWXpPaw?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE5WR0VkYzRib0dyR21wUXU0Tzg4XzJSOTVKOXE2LWloMjdFTnJRaml5NGdyeHFGYXNoYU9MYzJndld4RjY5d0lHWDZaSWZiTHcxSW9BdXBia3ZhTGY2T29GdWh5dEowUlR5ajdIWXpPaw</guid><pubDate>Mon, 17 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE5WR0VkYzRib0dyR21wUXU0Tzg4XzJSOTVKOXE2LWloMjdFTnJRaml5NGdyeHFGYXNoYU9MYzJndld4RjY5d0lHWDZaSWZiTHcxSW9BdXBia3ZhTGY2T29GdWh5dEowUlR5ajdIWXpPaw?oc=5" target="_blank"&gt;환인제약, 3Q 매출 1901억 원…상품 매출 성장에도 영업이익 44% ↓&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>[제약공시 책갈피] 12월 2주차 - 환인제약·동국·경동·진양 外 - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5pU2YzTUJqNzBrZExyN2hLUzRFMWVhQkdRLVZqR2lKanNGUHhhZnowMjd6XzB0MWUyQU15cXp5SmVUVWJkQ3JGeXhSbS1ZNm9KSV8wOGF5a1R3UWtLaGZHek11cThTSzBrVF9R?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5pU2YzTUJqNzBrZExyN2hLUzRFMWVhQkdRLVZqR2lKanNGUHhhZnowMjd6XzB0MWUyQU15cXp5SmVUVWJkQ3JGeXhSbS1ZNm9KSV8wOGF5a1R3UWtLaGZHek11cThTSzBrVF9R</guid><pubDate>Sat, 13 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5pU2YzTUJqNzBrZExyN2hLUzRFMWVhQkdRLVZqR2lKanNGUHhhZnowMjd6XzB0MWUyQU15cXp5SmVUVWJkQ3JGeXhSbS1ZNm9KSV8wOGF5a1R3UWtLaGZHek11cThTSzBrVF9R?oc=5" target="_blank"&gt;[제약공시 책갈피] 12월 2주차 - 환인제약·동국·경동·진양 外&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>환인제약, 동국·경동·진양과 자사주 맞교환…상법개정안 대응 차원 - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTFBKUFVsR0tqZGYxdllncjdWQVBYU3JZcUNKRGJjendkcEhEa1NTM1lSY1N5N1BMa1gwOUxsUmlsVUI0X2Y3Rkc2Y2hLaUVlSk1VMFlncHhFWWpiQdIBVEFVX3lxTFBfUGd4UXd4d2hVNGhieTVfSmhZZFlVQTl4dUpYdm9yNExENVc4akJLTmVHTUJpTk5NbXhrRXc2aFNlR0pzaEVQd3haLWNZdTNRWVYwQw?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTFBKUFVsR0tqZGYxdllncjdWQVBYU3JZcUNKRGJjendkcEhEa1NTM1lSY1N5N1BMa1gwOUxsUmlsVUI0X2Y3Rkc2Y2hLaUVlSk1VMFlncHhFWWpiQdIBVEFVX3lxTFBfUGd4UXd4d2hVNGhieTVfSmhZZFlVQTl4dUpYdm9yNExENVc4akJLTmVHTUJpTk5NbXhrRXc2aFNlR0pzaEVQd3haLWNZdTNRWVYwQw</guid><pubDate>Fri, 12 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTFBKUFVsR0tqZGYxdllncjdWQVBYU3JZcUNKRGJjendkcEhEa1NTM1lSY1N5N1BMa1gwOUxsUmlsVUI0X2Y3Rkc2Y2hLaUVlSk1VMFlncHhFWWpiQdIBVEFVX3lxTFBfUGd4UXd4d2hVNGhieTVfSmhZZFlVQTl4dUpYdm9yNExENVc4akJLTmVHTUJpTk5NbXhrRXc2aFNlR0pzaEVQd3haLWNZdTNRWVYwQw?oc=5" target="_blank"&gt;환인제약, 동국·경동·진양과 자사주 맞교환…상법개정안 대응 차원&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>환인제약, 궤양성 대장염 치료제 ‘토파시즈정 10mg’ 출시 … 치료 옵션 확대 - 헬스코리아뉴스</title><link>https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1CVVpXZEhIVE10VElzNnpnMEswT085ZjBSZGRJakM4Y0EyZWNkdlFBaWRfU2tjeUxucHZPQlQ3TEUwbHMyVEpfZkF1ODZlM1IxVXgyMFRzRmt6eTBLTXVRVkd4NXczTFE?oc=5</link><guid isPermaLink="false">CBMiZ0FVX3lxTE1CVVpXZEhIVE10VElzNnpnMEswT085ZjBSZGRJakM4Y0EyZWNkdlFBaWRfU2tjeUxucHZPQlQ3TEUwbHMyVEpfZkF1ODZlM1IxVXgyMFRzRmt6eTBLTXVRVkd4NXczTFE</guid><pubDate>Mon, 02 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1CVVpXZEhIVE10VElzNnpnMEswT085ZjBSZGRJakM4Y0EyZWNkdlFBaWRfU2tjeUxucHZPQlQ3TEUwbHMyVEpfZkF1ODZlM1IxVXgyMFRzRmt6eTBLTXVRVkd4NXczTFE?oc=5" target="_blank"&gt;환인제약, 궤양성 대장염 치료제 ‘토파시즈정 10mg’ 출시 … 치료 옵션 확대&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;헬스코리아뉴스&lt;/font&gt;</description><source url="https://www.hkn24.com">헬스코리아뉴스</source></item><item><title>중추신경계 약품 라이벌 환인제약 명인제약, 이광식 이행명 지배력과 경영승계는 달랐다 - 비즈니스포스트</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTFBFLXpLdU4yNjhLNWtoOE9GUVQ5blllUmV4dVl0QjI1SDRRc0NoVUxFbm16dUpaaGVuR281N0ZCanZET3hnU2J1SGFzZXJIMV9LRUV6aHEtUE14NU9DNF9YRnZST1ozMUVEcVFFZjZoV1hRTnM?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTFBFLXpLdU4yNjhLNWtoOE9GUVQ5blllUmV4dVl0QjI1SDRRc0NoVUxFbm16dUpaaGVuR281N0ZCanZET3hnU2J1SGFzZXJIMV9LRUV6aHEtUE14NU9DNF9YRnZST1ozMUVEcVFFZjZoV1hRTnM</guid><pubDate>Mon, 20 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTFBFLXpLdU4yNjhLNWtoOE9GUVQ5blllUmV4dVl0QjI1SDRRc0NoVUxFbm16dUpaaGVuR281N0ZCanZET3hnU2J1SGFzZXJIMV9LRUV6aHEtUE14NU9DNF9YRnZST1ozMUVEcVFFZjZoV1hRTnM?oc=5" target="_blank"&gt;중추신경계 약품 라이벌 환인제약 명인제약, 이광식 이행명 지배력과 경영승계는 달랐다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;비즈니스포스트&lt;/font&gt;</description><source url="https://www.businesspost.co.kr">비즈니스포스트</source></item><item><title>환인제약, 지난해 영업이익 130억…전년 대비 39.4% 감소 - 블로터</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE5raXM3a1V2WmlPU21haXZiZy12SnZTWGMxMHVwU21kM3I0OWxHZ0U4cmFjRUFRY1J4S0YtQVZMbFJjam9pbk9oclZ4aWZyYnBFbWlWMThBR2p5MHg4ekE1S3owYkVMOTlo0gFsQVVfeXFMTU1DZGYxR1dhR0RsbnlqellSU2FqVm9yY3ZENXpKQ293M1pCNWtxaGhPcWhnX2tNcTdOVzVnZnNyOXVQME1USU40N1VMSkpkalMwWGV6QmlKX1lsSzQ5Rkk0RFRETjE2ZXY1cVl3?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE5raXM3a1V2WmlPU21haXZiZy12SnZTWGMxMHVwU21kM3I0OWxHZ0U4cmFjRUFRY1J4S0YtQVZMbFJjam9pbk9oclZ4aWZyYnBFbWlWMThBR2p5MHg4ekE1S3owYkVMOTlo0gFsQVVfeXFMTU1DZGYxR1dhR0RsbnlqellSU2FqVm9yY3ZENXpKQ293M1pCNWtxaGhPcWhnX2tNcTdOVzVnZnNyOXVQME1USU40N1VMSkpkalMwWGV6QmlKX1lsSzQ5Rkk0RFRETjE2ZXY1cVl3</guid><pubDate>Fri, 13 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE5raXM3a1V2WmlPU21haXZiZy12SnZTWGMxMHVwU21kM3I0OWxHZ0U4cmFjRUFRY1J4S0YtQVZMbFJjam9pbk9oclZ4aWZyYnBFbWlWMThBR2p5MHg4ekE1S3owYkVMOTlo0gFsQVVfeXFMTU1DZGYxR1dhR0RsbnlqellSU2FqVm9yY3ZENXpKQ293M1pCNWtxaGhPcWhnX2tNcTdOVzVnZnNyOXVQME1USU40N1VMSkpkalMwWGV6QmlKX1lsSzQ5Rkk0RFRETjE2ZXY1cVl3?oc=5" target="_blank"&gt;환인제약, 지난해 영업이익 130억…전년 대비 39.4% 감소&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;블로터&lt;/font&gt;</description><source url="https://www.bloter.net">블로터</source></item><item><title>환인제약 '애즈유'-'라우드코퍼레이션' 전략적 파트너십 체결 - 메드월드뉴스</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE9wY0VDdENvc1BhU2lmd1BieDFxWWptdFhESnFyVWk2bmlNZzJEa05JSDZsNXJCcktKZEo4aHhHLVdwekZHX3I1cUZoUUVBNFdSTDhuOXBMOUo2VEgtOXpfM2FoMXFaOFVwVEdBcURn?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE9wY0VDdENvc1BhU2lmd1BieDFxWWptdFhESnFyVWk2bmlNZzJEa05JSDZsNXJCcktKZEo4aHhHLVdwekZHX3I1cUZoUUVBNFdSTDhuOXBMOUo2VEgtOXpfM2FoMXFaOFVwVEdBcURn</guid><pubDate>Thu, 23 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9wY0VDdENvc1BhU2lmd1BieDFxWWptdFhESnFyVWk2bmlNZzJEa05JSDZsNXJCcktKZEo4aHhHLVdwekZHX3I1cUZoUUVBNFdSTDhuOXBMOUo2VEgtOXpfM2FoMXFaOFVwVEdBcURn?oc=5" target="_blank"&gt;환인제약 '애즈유'-'라우드코퍼레이션' 전략적 파트너십 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메드월드뉴스&lt;/font&gt;</description><source url="https://www.medworld.co.kr">메드월드뉴스</source></item><item><title>이원범 환인제약 경영수업 20년 만에 최대주주에, 수익성과 신약개발 부진 돌파할 장벽 많다 - 비즈니스포스트</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE5oaE9NWUNSWjFWX2ZfVXV2Q1FNQ2pOTFh0UWtMUVVkTkhFRGZoejRVZTdzS0ZpeXUtTjh4alBXbzBiNEZkbkVSSndmLTJlZENFcGsxa05WWUstR1lhMldCbkFYaFdzRVlTUlBNMmlTWHhoRU0?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE5oaE9NWUNSWjFWX2ZfVXV2Q1FNQ2pOTFh0UWtMUVVkTkhFRGZoejRVZTdzS0ZpeXUtTjh4alBXbzBiNEZkbkVSSndmLTJlZENFcGsxa05WWUstR1lhMldCbkFYaFdzRVlTUlBNMmlTWHhoRU0</guid><pubDate>Mon, 20 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE5oaE9NWUNSWjFWX2ZfVXV2Q1FNQ2pOTFh0UWtMUVVkTkhFRGZoejRVZTdzS0ZpeXUtTjh4alBXbzBiNEZkbkVSSndmLTJlZENFcGsxa05WWUstR1lhMldCbkFYaFdzRVlTUlBNMmlTWHhoRU0?oc=5" target="_blank"&gt;이원범 환인제약 경영수업 20년 만에 최대주주에, 수익성과 신약개발 부진 돌파할 장벽 많다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;비즈니스포스트&lt;/font&gt;</description><source url="https://www.businesspost.co.kr">비즈니스포스트</source></item><item><title>환인제약, ‘토파시즈정5mg’ 발매 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFBXWjJIckZ1SkJERk9MZWJRT2FJM0x3SkMya1BtQ2huODI0dkFNX2VRZWtoVnFtM3F0cXhVUEJRaGhoaTNCaFJfWmdYQ2pVMUUycW5xY0M1SDZsa1hmVVhPNU1XbFNkYWh2ZXc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFBXWjJIckZ1SkJERk9MZWJRT2FJM0x3SkMya1BtQ2huODI0dkFNX2VRZWtoVnFtM3F0cXhVUEJRaGhoaTNCaFJfWmdYQ2pVMUUycW5xY0M1SDZsa1hmVVhPNU1XbFNkYWh2ZXc</guid><pubDate>Mon, 24 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBXWjJIckZ1SkJERk9MZWJRT2FJM0x3SkMya1BtQ2huODI0dkFNX2VRZWtoVnFtM3F0cXhVUEJRaGhoaTNCaFJfWmdYQ2pVMUUycW5xY0M1SDZsa1hmVVhPNU1XbFNkYWh2ZXc?oc=5" target="_blank"&gt;환인제약, ‘토파시즈정5mg’ 발매&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>‘CNS 강자’ 환인제약, 영업익 둔화 속 ‘제약사 4자 자사주 동맹’ 선택한 이유 - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE41MWtaVGZ4dFFXakpNOG1KRFE0NkFlY2QzbEVaNk4xbThfZWlKWjBVdExTdkhhYVpLWWtmTDdrTGFRT2FUbk9PTU5OZFBTVF9wbWFmay1jdzJHWk5fRVlzS3gtb2NfQkk2cXh4adIBcEFVX3lxTE5LeE8tcjNaX3czSkhHcmsxd3pMN2RtRkJjckVzYV9FeTZiVkJBVVZvcHJGdmw3QmNJdHVEWlE3aEs2akt1VjdjcDNEZzR1LXdqTlNCZEMtbWFTS1hMdjYwUTVvUmRYSXV6MnBIOEpKQXk?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE41MWtaVGZ4dFFXakpNOG1KRFE0NkFlY2QzbEVaNk4xbThfZWlKWjBVdExTdkhhYVpLWWtmTDdrTGFRT2FUbk9PTU5OZFBTVF9wbWFmay1jdzJHWk5fRVlzS3gtb2NfQkk2cXh4adIBcEFVX3lxTE5LeE8tcjNaX3czSkhHcmsxd3pMN2RtRkJjckVzYV9FeTZiVkJBVVZvcHJGdmw3QmNJdHVEWlE3aEs2akt1VjdjcDNEZzR1LXdqTlNCZEMtbWFTS1hMdjYwUTVvUmRYSXV6MnBIOEpKQXk</guid><pubDate>Mon, 22 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE41MWtaVGZ4dFFXakpNOG1KRFE0NkFlY2QzbEVaNk4xbThfZWlKWjBVdExTdkhhYVpLWWtmTDdrTGFRT2FUbk9PTU5OZFBTVF9wbWFmay1jdzJHWk5fRVlzS3gtb2NfQkk2cXh4adIBcEFVX3lxTE5LeE8tcjNaX3czSkhHcmsxd3pMN2RtRkJjckVzYV9FeTZiVkJBVVZvcHJGdmw3QmNJdHVEWlE3aEs2akt1VjdjcDNEZzR1LXdqTlNCZEMtbWFTS1hMdjYwUTVvUmRYSXV6MnBIOEpKQXk?oc=5" target="_blank"&gt;‘CNS 강자’ 환인제약, 영업익 둔화 속 ‘제약사 4자 자사주 동맹’ 선택한 이유&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item></channel></rss>